x_amount_mg	x_annotation	x_mmoles_per_liter	pert_dose	mfc_plate_name	x_avg_mol_weight	x_volume_ul	pert_mfc_desc	x_purity	pert_id_vendor	pert_well	pert_vehicle	pert_mfc_id	x_smiles	x_mg_per_ml	pert_dose_unit	pert_plate	pert_type	pert_id	pert_iname	pert_idose
0	-666	-666	-666	C-5001-01-LM3-035	-666	12	BO	-666	-666	A01	DMSO	-666	-666	-666	-666	ASG003	lma_x	CMAP-001	bo	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	12	RMCF7	-666	-666	A02	DMSO	-666	-666	-666	-666	ASG003	lma_x	CMAP-002	rmcf7	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	12	-666	-666	-666	A03	DMSO	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0.03688	-666	10	10	C-5001-01-LM3-035	307.3432	12	LY-294,002 HYDROCHLORIDE	-666	L9908	A04	DMSO	BRD-K27305650-001-09-1	O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1	3.073432	um	ASG003	trt_cp	BRD-K27305650	LY-294002	10 um
0.00369	-666	1	1	C-5001-01-LM3-035	307.3432	12	LY-294,002 HYDROCHLORIDE	-666	L9908	A05	DMSO	BRD-K27305650-001-09-1	O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1	0.3073432	um	ASG003	trt_cp	BRD-K27305650	LY-294002	1 um
0.00037	-666	0.1	0.1	C-5001-01-LM3-035	307.3432	12	LY-294,002 HYDROCHLORIDE	-666	L9908	A06	DMSO	BRD-K27305650-001-09-1	O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1	0.03073432	um	ASG003	trt_cp	BRD-K27305650	LY-294002	100 nm
0.05634	-666	10	10	C-5001-01-LM3-035	469.53652	12	BEZ-235	-666	-666	A07	DMSO	BRD-K12184916-001-02-2	Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1	4.6953652	um	ASG003	trt_cp	BRD-K12184916	NVP-BEZ235	10 um
0.00563	-666	1	1	C-5001-01-LM3-035	469.53652	12	BEZ-235	-666	-666	A08	DMSO	BRD-K12184916-001-02-2	Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1	0.46953652	um	ASG003	trt_cp	BRD-K12184916	NVP-BEZ235	1 um
0.00056	-666	0.1	0.1	C-5001-01-LM3-035	469.53652	12	BEZ-235	-666	-666	A09	DMSO	BRD-K12184916-001-02-2	Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1	0.046953652	um	ASG003	trt_cp	BRD-K12184916	NVP-BEZ235	100 nm
0.03689	-666	10	10	C-5001-01-LM3-035	307.3895	12	ZOLPIDEM	-666	1505369	A10	DMSO	BRD-K44876623-001-03-7	CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1	3.073895	um	ASG003	trt_cp	BRD-K44876623	zolpidem	10 um
0.00369	-666	1	1	C-5001-01-LM3-035	307.3895	12	ZOLPIDEM	-666	1505369	A11	DMSO	BRD-K44876623-001-03-7	CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1	0.3073895	um	ASG003	trt_cp	BRD-K44876623	zolpidem	1 um
0.00037	-666	0.1	0.1	C-5001-01-LM3-035	307.3895	12	ZOLPIDEM	-666	1505369	A12	DMSO	BRD-K44876623-001-03-7	CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1	0.03073895	um	ASG003	trt_cp	BRD-K44876623	zolpidem	100 nm
0.02968	-666	10	10	C-5001-01-LM3-035	247.293	12	PARBENDAZOLE	-666	Prestw-1110	A13	DMSO	BRD-K02407574-001-04-8	CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1	2.47293	um	ASG003	trt_cp	BRD-K02407574	parbendazole	10 um
0.00297	-666	1	1	C-5001-01-LM3-035	247.293	12	PARBENDAZOLE	-666	Prestw-1110	A14	DMSO	BRD-K02407574-001-04-8	CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1	0.247293	um	ASG003	trt_cp	BRD-K02407574	parbendazole	1 um
0.0003	-666	0.1	0.1	C-5001-01-LM3-035	247.293	12	PARBENDAZOLE	-666	Prestw-1110	A15	DMSO	BRD-K02407574-001-04-8	CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1	0.0247293	um	ASG003	trt_cp	BRD-K02407574	parbendazole	100 nm
0.05575	-666	10	10	C-5001-01-LM3-035	464.586	12	VX-680	-666	S1048	A16	DMSO	BRD-K59369769-001-21-1	CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1	4.64586	um	ASG003	trt_cp	BRD-K59369769	tozasertib	10 um
0.00558	-666	1	1	C-5001-01-LM3-035	464.586	12	VX-680	-666	S1048	A17	DMSO	BRD-K59369769-001-21-1	CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1	0.464586	um	ASG003	trt_cp	BRD-K59369769	tozasertib	1 um
0.00056	-666	0.1	0.1	C-5001-01-LM3-035	464.586	12	VX-680	-666	S1048	A18	DMSO	BRD-K59369769-001-21-1	CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1	0.0464586	um	ASG003	trt_cp	BRD-K59369769	tozasertib	100 nm
0.03484	-666	10	10	C-5001-01-LM3-035	290.3575	12	PROCATEROL HYDROCHLORIDE	-666	1102	A19	DMSO	BRD-A22684332-001-01-9	CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12	2.903575	um	ASG003	trt_cp	BRD-A22684332	procaterol	10 um
0.00348	-666	1	1	C-5001-01-LM3-035	290.3575	12	PROCATEROL HYDROCHLORIDE	-666	1102	A20	DMSO	BRD-A22684332-001-01-9	CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12	0.2903575	um	ASG003	trt_cp	BRD-A22684332	procaterol	1 um
0.00035	-666	0.1	0.1	C-5001-01-LM3-035	290.3575	12	PROCATEROL HYDROCHLORIDE	-666	1102	A21	DMSO	BRD-A22684332-001-01-9	CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12	0.02903575	um	ASG003	trt_cp	BRD-A22684332	procaterol	100 nm
0.03508	-666	10	10	C-5001-01-LM3-035	292.373	12	RITA (NSC 652287)	-666	S2781	A22	DMSO	BRD-K00317371-001-07-9	OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1	2.92373	um	ASG003	trt_cp	BRD-K00317371	RITA	10 um
0.00351	-666	1	1	C-5001-01-LM3-035	292.373	12	RITA (NSC 652287)	-666	S2781	A23	DMSO	BRD-K00317371-001-07-9	OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1	0.292373	um	ASG003	trt_cp	BRD-K00317371	RITA	1 um
0.00035	-666	0.1	0.1	C-5001-01-LM3-035	292.373	12	RITA (NSC 652287)	-666	S2781	A24	DMSO	BRD-K00317371-001-07-9	OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1	0.0292373	um	ASG003	trt_cp	BRD-K00317371	RITA	100 nm
0	-666	-666	-666	C-5001-01-LM3-035	-666	12	PMCF7	-666	-666	B01	DMSO	-666	-666	-666	-666	ASG003	lma_x	CMAP-003	pmcf7	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	12	RMCF7	-666	-666	B02	DMSO	-666	-666	-666	-666	ASG003	lma_x	CMAP-002	rmcf7	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	12	-666	-666	-666	B03	DMSO	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0.05297	-666	10	10	C-5001-01-LM3-035	441.452	12	R547	-666	S2688	B04	DMSO	BRD-K52233191-001-01-6	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(CC2)S(C)(=O)=O)nc1N	4.41452	um	ASG003	trt_cp	BRD-K52233191	r547	10 um
0.0053	-666	1	1	C-5001-01-LM3-035	441.452	12	R547	-666	S2688	B05	DMSO	BRD-K52233191-001-01-6	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(CC2)S(C)(=O)=O)nc1N	0.441452	um	ASG003	trt_cp	BRD-K52233191	r547	1 um
0.00053	-666	0.1	0.1	C-5001-01-LM3-035	441.452	12	R547	-666	S2688	B06	DMSO	BRD-K52233191-001-01-6	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(CC2)S(C)(=O)=O)nc1N	0.0441452	um	ASG003	trt_cp	BRD-K52233191	r547	100 nm
0.03237	-666	10	10	C-5001-01-LM3-035	269.726	12	ONCRASIN 1	-666	3427	B07	DMSO	BRD-K43449605-001-01-0	Clc1ccc(Cn2cc(C=O)c3ccccc23)cc1	2.69726	um	ASG003	trt_cp	BRD-K43449605	oncrasin-1	10 um
0.00324	-666	1	1	C-5001-01-LM3-035	269.726	12	ONCRASIN 1	-666	3427	B08	DMSO	BRD-K43449605-001-01-0	Clc1ccc(Cn2cc(C=O)c3ccccc23)cc1	0.269726	um	ASG003	trt_cp	BRD-K43449605	oncrasin-1	1 um
0.00032	-666	0.1	0.1	C-5001-01-LM3-035	269.726	12	ONCRASIN 1	-666	3427	B09	DMSO	BRD-K43449605-001-01-0	Clc1ccc(Cn2cc(C=O)c3ccccc23)cc1	0.0269726	um	ASG003	trt_cp	BRD-K43449605	oncrasin-1	100 nm
0.02954	-666	10	10	C-5001-01-LM3-035	246.1924	12	FLOXURIDINE	-666	S1299	B10	DMSO	BRD-K47832606-001-13-7	OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O	2.461924	um	ASG003	trt_cp	BRD-K47832606	floxuridine	10 um
0.00295	-666	1	1	C-5001-01-LM3-035	246.1924	12	FLOXURIDINE	-666	S1299	B11	DMSO	BRD-K47832606-001-13-7	OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O	0.2461924	um	ASG003	trt_cp	BRD-K47832606	floxuridine	1 um
0.0003	-666	0.1	0.1	C-5001-01-LM3-035	246.1924	12	FLOXURIDINE	-666	S1299	B12	DMSO	BRD-K47832606-001-13-7	OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O	0.02461924	um	ASG003	trt_cp	BRD-K47832606	floxuridine	100 nm
0.04097	-666	10	10	C-5001-01-LM3-035	341.42582	12	(S)-(-)-SULPIRIDE	-666	895	B13	DMSO	BRD-K51671335-001-04-9	CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	3.4142582	um	ASG003	trt_cp	BRD-K51671335	sulpiride	10 um
0.0041	-666	1	1	C-5001-01-LM3-035	341.42582	12	(S)-(-)-SULPIRIDE	-666	895	B14	DMSO	BRD-K51671335-001-04-9	CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	0.34142582	um	ASG003	trt_cp	BRD-K51671335	sulpiride	1 um
0.00041	-666	0.1	0.1	C-5001-01-LM3-035	341.42582	12	(S)-(-)-SULPIRIDE	-666	895	B15	DMSO	BRD-K51671335-001-04-9	CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	0.034142582	um	ASG003	trt_cp	BRD-K51671335	sulpiride	100 nm
0.04721	-666	10	10	C-5001-01-LM3-035	393.4357	12	ERLOTINIB HCL	-666	S1023	B16	DMSO	BRD-K70401845-001-09-0	COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC	3.934357	um	ASG003	trt_cp	BRD-K70401845	erlotinib	10 um
0.00472	-666	1	1	C-5001-01-LM3-035	393.4357	12	ERLOTINIB HCL	-666	S1023	B17	DMSO	BRD-K70401845-001-09-0	COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC	0.3934357	um	ASG003	trt_cp	BRD-K70401845	erlotinib	1 um
0.00047	-666	0.1	0.1	C-5001-01-LM3-035	393.4357	12	ERLOTINIB HCL	-666	S1023	B18	DMSO	BRD-K70401845-001-09-0	COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC	0.03934357	um	ASG003	trt_cp	BRD-K70401845	erlotinib	100 nm
0.043	-666	10	10	C-5001-01-LM3-035	358.3519	12	CV 1808	-666	1710	B19	DMSO	BRD-A64933752-001-02-8	Nc1nc(Nc2ccccc2)nc2n(cnc12)C1OC(CO)C(O)C1O	3.583519	um	ASG003	trt_cp	BRD-A64933752	CV-1808	10 um
0.0043	-666	1	1	C-5001-01-LM3-035	358.3519	12	CV 1808	-666	1710	B20	DMSO	BRD-A64933752-001-02-8	Nc1nc(Nc2ccccc2)nc2n(cnc12)C1OC(CO)C(O)C1O	0.3583519	um	ASG003	trt_cp	BRD-A64933752	CV-1808	1 um
0.00043	-666	0.1	0.1	C-5001-01-LM3-035	358.3519	12	CV 1808	-666	1710	B21	DMSO	BRD-A64933752-001-02-8	Nc1nc(Nc2ccccc2)nc2n(cnc12)C1OC(CO)C(O)C1O	0.03583519	um	ASG003	trt_cp	BRD-A64933752	CV-1808	100 nm
0.04687	-666	10	10	C-5001-01-LM3-035	390.5594	12	PDMP	-666	BML-SL210	B22	DMSO	BRD-K05653692-001-03-3	CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1	3.905594	um	ASG003	trt_cp	BRD-K05653692	DL-PDMP	10 um
0.00469	-666	1	1	C-5001-01-LM3-035	390.5594	12	PDMP	-666	BML-SL210	B23	DMSO	BRD-K05653692-001-03-3	CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1	0.3905594	um	ASG003	trt_cp	BRD-K05653692	DL-PDMP	1 um
0.00047	-666	0.1	0.1	C-5001-01-LM3-035	390.5594	12	PDMP	-666	BML-SL210	B24	DMSO	BRD-K05653692-001-03-3	CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1	0.03905594	um	ASG003	trt_cp	BRD-K05653692	DL-PDMP	100 nm
0.07644	-666	10	10	C-5001-01-LM3-035	637.027	12	SORAFENIB TOSYLATE	-666	S1040	C01	DMSO	BRD-K23984367-075-05-3	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1	6.37027	um	ASG003	trt_cp	BRD-K23984367	sorafenib	10 um
0.00764	-666	1	1	C-5001-01-LM3-035	637.027	12	SORAFENIB TOSYLATE	-666	S1040	C02	DMSO	BRD-K23984367-075-05-3	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1	0.637027	um	ASG003	trt_cp	BRD-K23984367	sorafenib	1 um
0.00076	-666	0.1	0.1	C-5001-01-LM3-035	637.027	12	SORAFENIB TOSYLATE	-666	S1040	C03	DMSO	BRD-K23984367-075-05-3	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1	0.0637027	um	ASG003	trt_cp	BRD-K23984367	sorafenib	100 nm
0.0696	-666	10	10	C-5001-01-LM3-035	579.98	12	EPIRUBICIN HYDROCHOLORIDE (ELLENCE)	-666	S1223	C04	DMSO	BRD-K04548931-003-08-2	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	5.7998	um	ASG003	trt_cp	BRD-K04548931	pidorubicine	10 um
0.00696	-666	1	1	C-5001-01-LM3-035	579.98	12	EPIRUBICIN HYDROCHOLORIDE (ELLENCE)	-666	S1223	C05	DMSO	BRD-K04548931-003-08-2	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	0.57998	um	ASG003	trt_cp	BRD-K04548931	pidorubicine	1 um
0.0007	-666	0.1	0.1	C-5001-01-LM3-035	579.98	12	EPIRUBICIN HYDROCHOLORIDE (ELLENCE)	-666	S1223	C06	DMSO	BRD-K04548931-003-08-2	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	0.057998	um	ASG003	trt_cp	BRD-K04548931	pidorubicine	100 nm
0.04638	-666	10	10	C-5001-01-LM3-035	386.46952	12	AXITINIB (AG-013736)	-666	AG-013736	C07	DMSO	BRD-K29905972-001-01-4	CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1	3.8646952	um	ASG003	trt_cp	BRD-K29905972	axitinib	10 um
0.00464	-666	1	1	C-5001-01-LM3-035	386.46952	12	AXITINIB (AG-013736)	-666	AG-013736	C08	DMSO	BRD-K29905972-001-01-4	CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1	0.38646952	um	ASG003	trt_cp	BRD-K29905972	axitinib	1 um
0.00046	-666	0.1	0.1	C-5001-01-LM3-035	386.46952	12	AXITINIB (AG-013736)	-666	AG-013736	C09	DMSO	BRD-K29905972-001-01-4	CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1	0.038646952	um	ASG003	trt_cp	BRD-K29905972	axitinib	100 nm
0.04217	-666	10	10	C-5001-01-LM3-035	351.4388	12	TAMIBAROTENE	-666	T3205	C10	DMSO	BRD-K36627727-001-01-3	CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12	3.514388	um	ASG003	trt_cp	BRD-K36627727	tamibarotene	10 um
0.00422	-666	1	1	C-5001-01-LM3-035	351.4388	12	TAMIBAROTENE	-666	T3205	C11	DMSO	BRD-K36627727-001-01-3	CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12	0.3514388	um	ASG003	trt_cp	BRD-K36627727	tamibarotene	1 um
0.00042	-666	0.1	0.1	C-5001-01-LM3-035	351.4388	12	TAMIBAROTENE	-666	T3205	C12	DMSO	BRD-K36627727-001-01-3	CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12	0.03514388	um	ASG003	trt_cp	BRD-K36627727	tamibarotene	100 nm
0.05363	-666	10	10	C-5001-01-LM3-035	446.902	12	GEFITINIB	-666	S1025	C13	DMSO	BRD-K64052750-001-04-3	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1	4.46902	um	ASG003	trt_cp	BRD-K64052750	gefitinib	10 um
0.00536	-666	1	1	C-5001-01-LM3-035	446.902	12	GEFITINIB	-666	S1025	C14	DMSO	BRD-K64052750-001-04-3	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1	0.446902	um	ASG003	trt_cp	BRD-K64052750	gefitinib	1 um
0.00054	-666	0.1	0.1	C-5001-01-LM3-035	446.902	12	GEFITINIB	-666	S1025	C15	DMSO	BRD-K64052750-001-04-3	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1	0.0446902	um	ASG003	trt_cp	BRD-K64052750	gefitinib	100 nm
0.0322	-666	10	10	C-5001-01-LM3-035	268.3502	12	EQUILIN	-666	1500275	C16	DMSO	BRD-A88080608-001-03-4	CC12CCC3C(=CCc4cc(O)ccc34)C1CCC2=O	2.683502	um	ASG003	trt_cp	BRD-A88080608	equilin	10 um
0.00322	-666	1	1	C-5001-01-LM3-035	268.3502	12	EQUILIN	-666	1500275	C17	DMSO	BRD-A88080608-001-03-4	CC12CCC3C(=CCc4cc(O)ccc34)C1CCC2=O	0.2683502	um	ASG003	trt_cp	BRD-A88080608	equilin	1 um
0.00032	-666	0.1	0.1	C-5001-01-LM3-035	268.3502	12	EQUILIN	-666	1500275	C18	DMSO	BRD-A88080608-001-03-4	CC12CCC3C(=CCc4cc(O)ccc34)C1CCC2=O	0.02683502	um	ASG003	trt_cp	BRD-A88080608	equilin	100 nm
0.05707	-666	9.999562677	9.999562677	C-5001-01-LM3-035	475.6208	12	MG-132	-666	S2619	C19	DMSO	BRD-K60230970-001-19-1	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	4.756	um	ASG003	trt_cp	BRD-K60230970	MG-132	10 um
0.05707	-666	9.999562677	9.999562677	C-5001-01-LM3-035	475.6208	12	MG-132	-666	S2619	C20	DMSO	BRD-K60230970-001-19-1	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	4.756	um	ASG003	trt_cp	BRD-K60230970	MG-132	10 um
0.05707	-666	9.999562677	9.999562677	C-5001-01-LM3-035	475.6208	12	MG-132	-666	S2619	C21	DMSO	BRD-K60230970-001-19-1	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	4.756	um	ASG003	trt_cp	BRD-K60230970	MG-132	10 um
0.05707	-666	9.999562677	9.999562677	C-5001-01-LM3-035	475.6208	12	MG-132	-666	S2619	C22	DMSO	BRD-K60230970-001-19-1	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	4.756	um	ASG003	trt_cp	BRD-K60230970	MG-132	10 um
0.05707	-666	9.999562677	9.999562677	C-5001-01-LM3-035	475.6208	12	MG-132	-666	S2619	C23	DMSO	BRD-K60230970-001-19-1	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	4.756	um	ASG003	trt_cp	BRD-K60230970	MG-132	10 um
0.05707	-666	9.999562677	9.999562677	C-5001-01-LM3-035	475.6208	12	MG-132	-666	S2619	C24	DMSO	BRD-K60230970-001-19-1	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	4.756	um	ASG003	trt_cp	BRD-K60230970	MG-132	10 um
0.04962	-666	10	10	C-5001-01-LM3-035	413.49	12	OBATOCLAX MESYLATE	-666	S1057	D01	DMSO	BRD-K15600710-066-01-7	COC1=CC(=N\C\1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1	4.1349	um	ASG003	trt_cp	BRD-K15600710	obatoclax	10 um
0.00496	-666	1	1	C-5001-01-LM3-035	413.49	12	OBATOCLAX MESYLATE	-666	S1057	D02	DMSO	BRD-K15600710-066-01-7	COC1=CC(=N\C\1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1	0.41349	um	ASG003	trt_cp	BRD-K15600710	obatoclax	1 um
0.0005	-666	0.1	0.1	C-5001-01-LM3-035	413.49	12	OBATOCLAX MESYLATE	-666	S1057	D03	DMSO	BRD-K15600710-066-01-7	COC1=CC(=N\C\1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1	0.041349	um	ASG003	trt_cp	BRD-K15600710	obatoclax	100 nm
0.0626	-666	10	10	C-5001-01-LM3-035	521.6544	12	BI 2536	-666	CT-BI2536	D04	DMSO	BRD-K64890080-001-05-4	CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O	5.216544	um	ASG003	trt_cp	BRD-K64890080	BI-2536	10 um
0.00626	-666	1	1	C-5001-01-LM3-035	521.6544	12	BI 2536	-666	CT-BI2536	D05	DMSO	BRD-K64890080-001-05-4	CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O	0.5216544	um	ASG003	trt_cp	BRD-K64890080	BI-2536	1 um
0.00063	-666	0.1	0.1	C-5001-01-LM3-035	521.6544	12	BI 2536	-666	CT-BI2536	D06	DMSO	BRD-K64890080-001-05-4	CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O	0.05216544	um	ASG003	trt_cp	BRD-K64890080	BI-2536	100 nm
0.05214	-666	10	10	C-5001-01-LM3-035	434.4628	12	AZD2281(OLAPARIB)	-666	S1060	D07	DMSO	BRD-K02113016-001-02-2	Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1	4.344628	um	ASG003	trt_cp	BRD-K02113016	olaparib	10 um
0.00521	-666	1	1	C-5001-01-LM3-035	434.4628	12	AZD2281(OLAPARIB)	-666	S1060	D08	DMSO	BRD-K02113016-001-02-2	Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1	0.4344628	um	ASG003	trt_cp	BRD-K02113016	olaparib	1 um
0.00052	-666	0.1	0.1	C-5001-01-LM3-035	434.4628	12	AZD2281(OLAPARIB)	-666	S1060	D09	DMSO	BRD-K02113016-001-02-2	Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1	0.04344628	um	ASG003	trt_cp	BRD-K02113016	olaparib	100 nm
0.09371	-666	10	10	C-5001-01-LM3-035	780.9385	12	DIGOXIN	-666	D6003	D10	DMSO	BRD-K23478508-001-15-1	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	7.809385	um	ASG003	trt_cp	BRD-K23478508	digoxin	10 um
0.00937	-666	1	1	C-5001-01-LM3-035	780.9385	12	DIGOXIN	-666	D6003	D11	DMSO	BRD-K23478508-001-15-1	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	0.7809385	um	ASG003	trt_cp	BRD-K23478508	digoxin	1 um
0.00094	-666	0.1	0.1	C-5001-01-LM3-035	780.9385	12	DIGOXIN	-666	D6003	D12	DMSO	BRD-K23478508-001-15-1	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	0.07809385	um	ASG003	trt_cp	BRD-K23478508	digoxin	100 nm
0.06752	-666	10	10	C-5001-01-LM3-035	562.70298	12	TANDUTINIB (MLN518, CT53518)	-666	MLN518, CT53518	D13	DMSO	BRD-K89162000-001-01-5	COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1	5.6270298	um	ASG003	trt_cp	BRD-K89162000	tandutinib	10 um
0.00675	-666	1	1	C-5001-01-LM3-035	562.70298	12	TANDUTINIB (MLN518, CT53518)	-666	MLN518, CT53518	D14	DMSO	BRD-K89162000-001-01-5	COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1	0.56270298	um	ASG003	trt_cp	BRD-K89162000	tandutinib	1 um
0.00068	-666	0.1	0.1	C-5001-01-LM3-035	562.70298	12	TANDUTINIB (MLN518, CT53518)	-666	MLN518, CT53518	D15	DMSO	BRD-K89162000-001-01-5	COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1	0.056270298	um	ASG003	trt_cp	BRD-K89162000	tandutinib	100 nm
0.06353	-666	10.4303333	10.4303333	C-5001-01-LM3-035	507.5599	12	BARASERTIB (AZD1152-HQPA)	-666	S1147	D16	DMSO	BRD-K63923597-001-11-8	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	5.294018927	um	ASG003	trt_cp	BRD-K63923597	barasertib	10 um
0.00635	-666	1.043033331	1.043033331	C-5001-01-LM3-035	507.5599	12	BARASERTIB (AZD1152-HQPA)	-666	S1147	D17	DMSO	BRD-K63923597-001-11-8	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	0.529401893	um	ASG003	trt_cp	BRD-K63923597	barasertib	1 um
0.00064	-666	0.104303332	0.104303332	C-5001-01-LM3-035	507.5599	12	BARASERTIB (AZD1152-HQPA)	-666	S1147	D18	DMSO	BRD-K63923597-001-11-8	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	0.052940189	um	ASG003	trt_cp	BRD-K63923597	barasertib	100 nm
0.06823	-666	10	10	C-5001-01-LM3-035	568.552	12	AMG 232	-666	HY-12296	D19	DMSO	BRD-K64925568-001-01-8	CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1	5.68552	um	ASG003	trt_cp	BRD-K64925568	amg-232	10 um
0.00682	-666	1	1	C-5001-01-LM3-035	568.552	12	AMG 232	-666	HY-12296	D20	DMSO	BRD-K64925568-001-01-8	CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1	0.568552	um	ASG003	trt_cp	BRD-K64925568	amg-232	1 um
0.00068	-666	0.1	0.1	C-5001-01-LM3-035	568.552	12	AMG 232	-666	HY-12296	D21	DMSO	BRD-K64925568-001-01-8	CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1	0.0568552	um	ASG003	trt_cp	BRD-K64925568	amg-232	100 nm
0.09683	-666	10	10	C-5001-01-LM3-035	806.9408	12	BIRINAPANT (TL32711)	-666	S7015	D22	DMSO	BRD-K71221037-001-02-4	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC	8.069408	um	ASG003	trt_cp	BRD-K71221037	birinapant	10 um
0.00968	-666	1	1	C-5001-01-LM3-035	806.9408	12	BIRINAPANT (TL32711)	-666	S7015	D23	DMSO	BRD-K71221037-001-02-4	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC	0.8069408	um	ASG003	trt_cp	BRD-K71221037	birinapant	1 um
0.00097	-666	0.1	0.1	C-5001-01-LM3-035	806.9408	12	BIRINAPANT (TL32711)	-666	S7015	D24	DMSO	BRD-K71221037-001-02-4	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC	0.08069408	um	ASG003	trt_cp	BRD-K71221037	birinapant	100 nm
0.04817	-666	10	10	C-5001-01-LM3-035	401.4314	12	MOXIFLOXACIN	-666	S1465	E01	DMSO	BRD-K66615216-001-01-9	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	4.014314	um	ASG003	trt_cp	BRD-K66615216	moxifloxacin	10 um
0.00482	-666	1	1	C-5001-01-LM3-035	401.4314	12	MOXIFLOXACIN	-666	S1465	E02	DMSO	BRD-K66615216-001-01-9	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	0.4014314	um	ASG003	trt_cp	BRD-K66615216	moxifloxacin	1 um
0.00048	-666	0.1	0.1	C-5001-01-LM3-035	401.4314	12	MOXIFLOXACIN	-666	S1465	E03	DMSO	BRD-K66615216-001-01-9	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	0.04014314	um	ASG003	trt_cp	BRD-K66615216	moxifloxacin	100 nm
0.05492	-666	10	10	C-5001-01-LM3-035	457.681	12	AZD6244	-666	S1008	E04	DMSO	BRD-K57080016-001-03-5	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO	4.57681	um	ASG003	trt_cp	BRD-K57080016	selumetinib	10 um
0.00549	-666	1	1	C-5001-01-LM3-035	457.681	12	AZD6244	-666	S1008	E05	DMSO	BRD-K57080016-001-03-5	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO	0.457681	um	ASG003	trt_cp	BRD-K57080016	selumetinib	1 um
0.00055	-666	0.1	0.1	C-5001-01-LM3-035	457.681	12	AZD6244	-666	S1008	E06	DMSO	BRD-K57080016-001-03-5	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO	0.0457681	um	ASG003	trt_cp	BRD-K57080016	selumetinib	100 nm
0.07546	-666	10	10	C-5001-01-LM3-035	628.8008	12	LOPINAVIR (ABT-378)	-666	S1380	E07	DMSO	BRD-K99451608-001-02-4	CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)Cc1ccccc1	6.288008	um	ASG003	trt_cp	BRD-K99451608	lopinavir	10 um
0.00755	-666	1	1	C-5001-01-LM3-035	628.8008	12	LOPINAVIR (ABT-378)	-666	S1380	E08	DMSO	BRD-K99451608-001-02-4	CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)Cc1ccccc1	0.6288008	um	ASG003	trt_cp	BRD-K99451608	lopinavir	1 um
0.00075	-666	0.1	0.1	C-5001-01-LM3-035	628.8008	12	LOPINAVIR (ABT-378)	-666	S1380	E09	DMSO	BRD-K99451608-001-02-4	CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)Cc1ccccc1	0.06288008	um	ASG003	trt_cp	BRD-K99451608	lopinavir	100 nm
0.04217	-666	10	10	C-5001-01-LM3-035	351.4388	12	AM-580	-666	GR-104	E10	DMSO	BRD-K06854232-001-07-4	CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O	3.514388	um	ASG003	trt_cp	BRD-K06854232	AM-580	10 um
0.00422	-666	1	1	C-5001-01-LM3-035	351.4388	12	AM-580	-666	GR-104	E11	DMSO	BRD-K06854232-001-07-4	CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O	0.3514388	um	ASG003	trt_cp	BRD-K06854232	AM-580	1 um
0.00042	-666	0.1	0.1	C-5001-01-LM3-035	351.4388	12	AM-580	-666	GR-104	E12	DMSO	BRD-K06854232-001-07-4	CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O	0.03514388	um	ASG003	trt_cp	BRD-K06854232	AM-580	100 nm
0.06896	-666	10	10	C-5001-01-LM3-035	574.6625	12	KW-2478	-666	S2685	E13	DMSO	BRD-K41213548-001-01-2	CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC	5.746625	um	ASG003	trt_cp	BRD-K41213548	kw-2478	10 um
0.0069	-666	1	1	C-5001-01-LM3-035	574.6625	12	KW-2478	-666	S2685	E14	DMSO	BRD-K41213548-001-01-2	CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC	0.5746625	um	ASG003	trt_cp	BRD-K41213548	kw-2478	1 um
0.00069	-666	0.1	0.1	C-5001-01-LM3-035	574.6625	12	KW-2478	-666	S2685	E15	DMSO	BRD-K41213548-001-01-2	CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC	0.05746625	um	ASG003	trt_cp	BRD-K41213548	kw-2478	100 nm
0.05587	-666	10	10	C-5001-01-LM3-035	465.5447	12	KU-0063794	-666	S1226	E16	DMSO	BRD-K67566344-001-01-8	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1	4.655447	um	ASG003	trt_cp	BRD-K67566344	KU-0063794	10 um
0.00559	-666	1	1	C-5001-01-LM3-035	465.5447	12	KU-0063794	-666	S1226	E17	DMSO	BRD-K67566344-001-01-8	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1	0.4655447	um	ASG003	trt_cp	BRD-K67566344	KU-0063794	1 um
0.00056	-666	0.1	0.1	C-5001-01-LM3-035	465.5447	12	KU-0063794	-666	S1226	E18	DMSO	BRD-K67566344-001-01-8	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1	0.04655447	um	ASG003	trt_cp	BRD-K67566344	KU-0063794	100 nm
0.05791	-666	10	10	C-5001-01-LM3-035	482.6166	12	ALECTINIB	-666	S2762	E19	DMSO	BRD-K11267252-001-05-1	CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1	4.826166	um	ASG003	trt_cp	BRD-K11267252	alectinib	10 um
0.00579	-666	1	1	C-5001-01-LM3-035	482.6166	12	ALECTINIB	-666	S2762	E20	DMSO	BRD-K11267252-001-05-1	CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1	0.4826166	um	ASG003	trt_cp	BRD-K11267252	alectinib	1 um
0.00058	-666	0.1	0.1	C-5001-01-LM3-035	482.6166	12	ALECTINIB	-666	S2762	E21	DMSO	BRD-K11267252-001-05-1	CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1	0.04826166	um	ASG003	trt_cp	BRD-K11267252	alectinib	100 nm
0.07967	-666	10	10	C-5001-01-LM3-035	663.888	12	NELFINAVIR MESYLATE	-666	DL566	E22	DMSO	BRD-K74117820-066-10-8	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C	6.63888	um	ASG003	trt_cp	BRD-K74117820	nelfinavir	10 um
0.00797	-666	1	1	C-5001-01-LM3-035	663.888	12	NELFINAVIR MESYLATE	-666	DL566	E23	DMSO	BRD-K74117820-066-10-8	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C	0.663888	um	ASG003	trt_cp	BRD-K74117820	nelfinavir	1 um
0.0008	-666	0.1	0.1	C-5001-01-LM3-035	663.888	12	NELFINAVIR MESYLATE	-666	DL566	E24	DMSO	BRD-K74117820-066-10-8	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C	0.0663888	um	ASG003	trt_cp	BRD-K74117820	nelfinavir	100 nm
0.10421	-666	10	10	C-5001-01-LM3-035	868.439	12	VENETOCLAX	-666	S8048	F01	DMSO	BRD-K62391742-001-08-9	CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1	8.68439	um	ASG003	trt_cp	BRD-K62391742	gdc-0199	10 um
0.01042	-666	1	1	C-5001-01-LM3-035	868.439	12	VENETOCLAX	-666	S8048	F02	DMSO	BRD-K62391742-001-08-9	CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1	0.868439	um	ASG003	trt_cp	BRD-K62391742	gdc-0199	1 um
0.00104	-666	0.1	0.1	C-5001-01-LM3-035	868.439	12	VENETOCLAX	-666	S8048	F03	DMSO	BRD-K62391742-001-08-9	CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1	0.0868439	um	ASG003	trt_cp	BRD-K62391742	gdc-0199	100 nm
0.03172	-666	10	10	C-5001-01-LM3-035	264.3202	12	VORINOSTAT	-666	10009929	F04	DMSO	BRD-K81418486-001-52-5	ONC(=O)CCCCCCC(=O)Nc1ccccc1	2.643202	um	ASG003	trt_cp	BRD-K81418486	vorinostat	10 um
0.00317	-666	1	1	C-5001-01-LM3-035	264.3202	12	VORINOSTAT	-666	10009929	F05	DMSO	BRD-K81418486-001-52-5	ONC(=O)CCCCCCC(=O)Nc1ccccc1	0.2643202	um	ASG003	trt_cp	BRD-K81418486	vorinostat	1 um
0.00032	-666	0.1	0.1	C-5001-01-LM3-035	264.3202	12	VORINOSTAT	-666	10009929	F06	DMSO	BRD-K81418486-001-52-5	ONC(=O)CCCCCCC(=O)Nc1ccccc1	0.02643202	um	ASG003	trt_cp	BRD-K81418486	vorinostat	100 nm
0.02535	-666	10	10	C-5001-01-LM3-035	211.2576	12	METAPROTERENOL HEMISULFATE SALT	-666	M225835	F07	DMSO	BRD-A07780951-001-06-3	CC(C)NCC(O)c1cc(O)cc(O)c1	2.112576	um	ASG003	trt_cp	BRD-A07780951	orciprenaline	10 um
0.00254	-666	1	1	C-5001-01-LM3-035	211.2576	12	METAPROTERENOL HEMISULFATE SALT	-666	M225835	F08	DMSO	BRD-A07780951-001-06-3	CC(C)NCC(O)c1cc(O)cc(O)c1	0.2112576	um	ASG003	trt_cp	BRD-A07780951	orciprenaline	1 um
0.00025	-666	0.1	0.1	C-5001-01-LM3-035	211.2576	12	METAPROTERENOL HEMISULFATE SALT	-666	M225835	F09	DMSO	BRD-A07780951-001-06-3	CC(C)NCC(O)c1cc(O)cc(O)c1	0.02112576	um	ASG003	trt_cp	BRD-A07780951	orciprenaline	100 nm
0.06728	-666	10	10	C-5001-01-LM3-035	560.667	12	QUIZARTINIB (AC220)	-666	S1526	F10	DMSO	BRD-K93918653-001-06-3	CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1	5.60667	um	ASG003	trt_cp	BRD-K93918653	quizartinib	10 um
0.00673	-666	1	1	C-5001-01-LM3-035	560.667	12	QUIZARTINIB (AC220)	-666	S1526	F11	DMSO	BRD-K93918653-001-06-3	CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1	0.560667	um	ASG003	trt_cp	BRD-K93918653	quizartinib	1 um
0.00067	-666	0.1	0.1	C-5001-01-LM3-035	560.667	12	QUIZARTINIB (AC220)	-666	S1526	F12	DMSO	BRD-K93918653-001-06-3	CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1	0.0560667	um	ASG003	trt_cp	BRD-K93918653	quizartinib	100 nm
0.0418	-666	10	10	C-5001-01-LM3-035	348.3553	12	PI-103	-666	S1038	F13	DMSO	BRD-K67868012-001-07-6	Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1	3.483553	um	ASG003	trt_cp	BRD-K67868012	PI-103	10 um
0.00418	-666	1	1	C-5001-01-LM3-035	348.3553	12	PI-103	-666	S1038	F14	DMSO	BRD-K67868012-001-07-6	Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1	0.3483553	um	ASG003	trt_cp	BRD-K67868012	PI-103	1 um
0.00042	-666	0.1	0.1	C-5001-01-LM3-035	348.3553	12	PI-103	-666	S1038	F15	DMSO	BRD-K67868012-001-07-6	Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1	0.03483553	um	ASG003	trt_cp	BRD-K67868012	PI-103	100 nm
0.06627	-666	11.1	11.1	C-5001-01-LM3-035	497.4939	12	4-DEMETHOXYDAUNORUBICIN HYDROCHLORIDE (65)	-666	I167000	F16	DMSO	BRD-A71390734-001-01-7	CC1OC(CC(N)C1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O	5.52218229	um	ASG003	trt_cp	BRD-A71390734	idarubicin	10 um
0.00663	-666	1.11	1.11	C-5001-01-LM3-035	497.4939	12	4-DEMETHOXYDAUNORUBICIN HYDROCHLORIDE (65)	-666	I167000	F17	DMSO	BRD-A71390734-001-01-7	CC1OC(CC(N)C1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O	0.552218229	um	ASG003	trt_cp	BRD-A71390734	idarubicin	1 um
0.00066	-666	0.111	0.111	C-5001-01-LM3-035	497.4939	12	4-DEMETHOXYDAUNORUBICIN HYDROCHLORIDE (65)	-666	I167000	F18	DMSO	BRD-A71390734-001-01-7	CC1OC(CC(N)C1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O	0.055221823	um	ASG003	trt_cp	BRD-A71390734	idarubicin	100 nm
0.07245	-666	10	10	C-5001-01-LM3-035	603.745	12	SALMETEROL XINAFOATE	-666	S5068	F19	DMSO	BRD-A01320529-104-07-7	OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1	6.03745	um	ASG003	trt_cp	BRD-A01320529	salmeterol	10 um
0.00724	-666	1	1	C-5001-01-LM3-035	603.745	12	SALMETEROL XINAFOATE	-666	S5068	F20	DMSO	BRD-A01320529-104-07-7	OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1	0.603745	um	ASG003	trt_cp	BRD-A01320529	salmeterol	1 um
0.00072	-666	0.1	0.1	C-5001-01-LM3-035	603.745	12	SALMETEROL XINAFOATE	-666	S5068	F21	DMSO	BRD-A01320529-104-07-7	OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1	0.0603745	um	ASG003	trt_cp	BRD-A01320529	salmeterol	100 nm
0.03797	-666	10	10	C-5001-01-LM3-035	316.4345	12	15-DEOXY-?12,14-PROSTAGLANDIN J2	-666	2306	F22	DMSO	BRD-K61033289-001-01-2	CCCCC\C=C\C=C1/[C@@H](C\C=C\CCCC(O)=O)C=CC1=O	3.164345	um	ASG003	trt_cp	BRD-K61033289	15-delta-prostaglandin-j2	10 um
0.0038	-666	1	1	C-5001-01-LM3-035	316.4345	12	15-DEOXY-?12,14-PROSTAGLANDIN J2	-666	2306	F23	DMSO	BRD-K61033289-001-01-2	CCCCC\C=C\C=C1/[C@@H](C\C=C\CCCC(O)=O)C=CC1=O	0.3164345	um	ASG003	trt_cp	BRD-K61033289	15-delta-prostaglandin-j2	1 um
0.00038	-666	0.1	0.1	C-5001-01-LM3-035	316.4345	12	15-DEOXY-?12,14-PROSTAGLANDIN J2	-666	2306	F24	DMSO	BRD-K61033289-001-01-2	CCCCC\C=C\C=C1/[C@@H](C\C=C\CCCC(O)=O)C=CC1=O	0.03164345	um	ASG003	trt_cp	BRD-K61033289	15-delta-prostaglandin-j2	100 nm
0.03423	-666	10	10	C-5001-01-LM3-035	285.2318	12	FLUDARABINE(FLUDARA)	-666	F425000	G01	DMSO	BRD-K66788707-001-07-7	Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	2.852318	um	ASG003	trt_cp	BRD-K66788707	fludarabine	10 um
0.00342	-666	1	1	C-5001-01-LM3-035	285.2318	12	FLUDARABINE(FLUDARA)	-666	F425000	G02	DMSO	BRD-K66788707-001-07-7	Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	0.2852318	um	ASG003	trt_cp	BRD-K66788707	fludarabine	1 um
0.00034	-666	0.1	0.1	C-5001-01-LM3-035	285.2318	12	FLUDARABINE(FLUDARA)	-666	F425000	G03	DMSO	BRD-K66788707-001-07-7	Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	0.02852318	um	ASG003	trt_cp	BRD-K66788707	fludarabine	100 nm
0.06805	-666	10	10	C-5001-01-LM3-035	567.05094	12	AMLODIPINE BESYLATE	-666	2571	G04	DMSO	BRD-A22032524-074-03-2	CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC	5.6705094	um	ASG003	trt_cp	BRD-A22032524	amlodipine	10 um
0.0068	-666	1	1	C-5001-01-LM3-035	567.05094	12	AMLODIPINE BESYLATE	-666	2571	G05	DMSO	BRD-A22032524-074-03-2	CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC	0.56705094	um	ASG003	trt_cp	BRD-A22032524	amlodipine	1 um
0.00068	-666	0.1	0.1	C-5001-01-LM3-035	567.05094	12	AMLODIPINE BESYLATE	-666	2571	G06	DMSO	BRD-A22032524-074-03-2	CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC	0.056705094	um	ASG003	trt_cp	BRD-A22032524	amlodipine	100 nm
0.06704	-666	10	10	C-5001-01-LM3-035	558.6398	12	ATORVASTATIN	-666	A791750	G07	DMSO	BRD-A82307304-001-01-8	CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)=O)-c1ccccc1	5.586398	um	ASG003	trt_cp	BRD-A82307304	atorvastatin	10 um
0.0067	-666	1	1	C-5001-01-LM3-035	558.6398	12	ATORVASTATIN	-666	A791750	G08	DMSO	BRD-A82307304-001-01-8	CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)=O)-c1ccccc1	0.5586398	um	ASG003	trt_cp	BRD-A82307304	atorvastatin	1 um
0.00067	-666	0.1	0.1	C-5001-01-LM3-035	558.6398	12	ATORVASTATIN	-666	A791750	G09	DMSO	BRD-A82307304-001-01-8	CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(O)=O)-c1ccccc1	0.05586398	um	ASG003	trt_cp	BRD-A82307304	atorvastatin	100 nm
0.05147	-666	10	10	C-5001-01-LM3-035	428.915	12	AZD5363	-666	S8019	G10	DMSO	BRD-K99023089-001-01-1	NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1	4.28915	um	ASG003	trt_cp	BRD-K99023089	azd5363	10 um
0.00515	-666	1	1	C-5001-01-LM3-035	428.915	12	AZD5363	-666	S8019	G11	DMSO	BRD-K99023089-001-01-1	NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1	0.428915	um	ASG003	trt_cp	BRD-K99023089	azd5363	1 um
0.00051	-666	0.1	0.1	C-5001-01-LM3-035	428.915	12	AZD5363	-666	S8019	G12	DMSO	BRD-K99023089-001-01-1	NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1	0.0428915	um	ASG003	trt_cp	BRD-K99023089	azd5363	100 nm
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	G13	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	G14	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	G15	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	G16	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	G17	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	G18	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0.04951	-666	10.00012874	10.00012874	C-5001-01-LM3-035	412.6047	12	CALCIPOTRIOL	-666	HY-10001	G19	DMSO	BRD-K56429665-001-09-6	C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	4.126100119	um	ASG003	trt_cp	BRD-K56429665	calcipotriol	10 um
0.00495	-666	1.000012874	1.000012874	C-5001-01-LM3-035	412.6047	12	CALCIPOTRIOL	-666	HY-10001	G20	DMSO	BRD-K56429665-001-09-6	C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	0.412610012	um	ASG003	trt_cp	BRD-K56429665	calcipotriol	1 um
0.0005	-666	0.100001287	0.100001287	C-5001-01-LM3-035	412.6047	12	CALCIPOTRIOL	-666	HY-10001	G21	DMSO	BRD-K56429665-001-09-6	C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	0.041261001	um	ASG003	trt_cp	BRD-K56429665	calcipotriol	100 nm
0.05	-666	10	10	C-5001-01-LM3-035	416.6365	12	1A,25-DIHYDROXYVITAMIN D3	-666	DM-200	G22	DMSO	BRD-K27316855-001-06-7	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	4.166365	um	ASG003	trt_cp	BRD-K27316855	calcitriol	10 um
0.005	-666	1	1	C-5001-01-LM3-035	416.6365	12	1A,25-DIHYDROXYVITAMIN D3	-666	DM-200	G23	DMSO	BRD-K27316855-001-06-7	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	0.4166365	um	ASG003	trt_cp	BRD-K27316855	calcitriol	1 um
0.0005	-666	0.1	0.1	C-5001-01-LM3-035	416.6365	12	1A,25-DIHYDROXYVITAMIN D3	-666	DM-200	G24	DMSO	BRD-K27316855-001-06-7	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	0.04166365	um	ASG003	trt_cp	BRD-K27316855	calcitriol	100 nm
0.04759	-666	10	10	C-5001-01-LM3-035	396.5622	12	ESTRADIOL CYPIONATE	-666	1500283	H01	DMSO	BRD-A91452556-001-03-2	C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1	3.965622	um	ASG003	trt_cp	BRD-A91452556	estradiol-cypionate	10 um
0.00476	-666	1	1	C-5001-01-LM3-035	396.5622	12	ESTRADIOL CYPIONATE	-666	1500283	H02	DMSO	BRD-A91452556-001-03-2	C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1	0.3965622	um	ASG003	trt_cp	BRD-A91452556	estradiol-cypionate	1 um
0.00048	-666	0.1	0.1	C-5001-01-LM3-035	396.5622	12	ESTRADIOL CYPIONATE	-666	1500283	H03	DMSO	BRD-A91452556-001-03-2	C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1	0.03965622	um	ASG003	trt_cp	BRD-A91452556	estradiol-cypionate	100 nm
0.05298	-666	10	10	C-5001-01-LM3-035	441.54	12	TROGLITAZONE	-666	GR-210	H04	DMSO	BRD-A13084692-001-08-2	Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O	4.4154	um	ASG003	trt_cp	BRD-A13084692	troglitazone	10 um
0.0053	-666	1	1	C-5001-01-LM3-035	441.54	12	TROGLITAZONE	-666	GR-210	H05	DMSO	BRD-A13084692-001-08-2	Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O	0.44154	um	ASG003	trt_cp	BRD-A13084692	troglitazone	1 um
0.00053	-666	0.1	0.1	C-5001-01-LM3-035	441.54	12	TROGLITAZONE	-666	GR-210	H06	DMSO	BRD-A13084692-001-08-2	Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O	0.044154	um	ASG003	trt_cp	BRD-A13084692	troglitazone	100 nm
0.05879	-666	10	10	C-5001-01-LM3-035	489.922	12	VEMURAFENIB (PLX4032)	-666	S1267	H07	DMSO	BRD-K56343971-001-08-0	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F	4.89922	um	ASG003	trt_cp	BRD-K56343971	vemurafenib	10 um
0.00588	-666	1	1	C-5001-01-LM3-035	489.922	12	VEMURAFENIB (PLX4032)	-666	S1267	H08	DMSO	BRD-K56343971-001-08-0	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F	0.489922	um	ASG003	trt_cp	BRD-K56343971	vemurafenib	1 um
0.00059	-666	0.1	0.1	C-5001-01-LM3-035	489.922	12	VEMURAFENIB (PLX4032)	-666	S1267	H09	DMSO	BRD-K56343971-001-08-0	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F	0.0489922	um	ASG003	trt_cp	BRD-K56343971	vemurafenib	100 nm
0.04348	-666	10	10	C-5001-01-LM3-035	362.3556	12	MARBOFLOXACIN	-666	S1464	H10	DMSO	BRD-K71926323-001-12-0	CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O	3.623556	um	ASG003	trt_cp	BRD-K71926323	marbofloxacin	10 um
0.00435	-666	1	1	C-5001-01-LM3-035	362.3556	12	MARBOFLOXACIN	-666	S1464	H11	DMSO	BRD-K71926323-001-12-0	CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O	0.3623556	um	ASG003	trt_cp	BRD-K71926323	marbofloxacin	1 um
0.00043	-666	0.1	0.1	C-5001-01-LM3-035	362.3556	12	MARBOFLOXACIN	-666	S1464	H12	DMSO	BRD-K71926323-001-12-0	CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O	0.03623556	um	ASG003	trt_cp	BRD-K71926323	marbofloxacin	100 nm
0.04519	-666	10	10	C-5001-01-LM3-035	376.5726	12	LITHOCHOLIC ACID	-666	BL-076	H13	DMSO	BRD-K20986251-001-07-2	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	3.765726	um	ASG003	trt_cp	BRD-K20986251	lithocholic-acid	10 um
0.00452	-666	1	1	C-5001-01-LM3-035	376.5726	12	LITHOCHOLIC ACID	-666	BL-076	H14	DMSO	BRD-K20986251-001-07-2	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	0.3765726	um	ASG003	trt_cp	BRD-K20986251	lithocholic-acid	1 um
0.00045	-666	0.1	0.1	C-5001-01-LM3-035	376.5726	12	LITHOCHOLIC ACID	-666	BL-076	H15	DMSO	BRD-K20986251-001-07-2	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	0.03765726	um	ASG003	trt_cp	BRD-K20986251	lithocholic-acid	100 nm
0.06235	-666	10	10	C-5001-01-LM3-035	519.562	12	DABRAFENIB	-666	S2807	H16	DMSO	BRD-K09951645-001-10-0	CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F	5.19562	um	ASG003	trt_cp	BRD-K09951645	dabrafenib	10 um
0.00623	-666	1	1	C-5001-01-LM3-035	519.562	12	DABRAFENIB	-666	S2807	H17	DMSO	BRD-K09951645-001-10-0	CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F	0.519562	um	ASG003	trt_cp	BRD-K09951645	dabrafenib	1 um
0.00062	-666	0.1	0.1	C-5001-01-LM3-035	519.562	12	DABRAFENIB	-666	S2807	H18	DMSO	BRD-K09951645-001-10-0	CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F	0.0519562	um	ASG003	trt_cp	BRD-K09951645	dabrafenib	100 nm
0.0418	-666	10	10	C-5001-01-LM3-035	348.352	12	CAMPTOTHECINE	-666	C9911	H19	DMSO	BRD-K37890730-001-11-0	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O	3.48352	um	ASG003	trt_cp	BRD-K37890730	camptothecin	10 um
0.00418	-666	1	1	C-5001-01-LM3-035	348.352	12	CAMPTOTHECINE	-666	C9911	H20	DMSO	BRD-K37890730-001-11-0	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O	0.348352	um	ASG003	trt_cp	BRD-K37890730	camptothecin	1 um
0.00042	-666	0.1	0.1	C-5001-01-LM3-035	348.352	12	CAMPTOTHECINE	-666	C9911	H21	DMSO	BRD-K37890730-001-11-0	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O	0.0348352	um	ASG003	trt_cp	BRD-K37890730	camptothecin	100 nm
0.03374	-666	9.520938792	9.520938792	C-5001-01-LM3-035	295.3358	12	PJ34	-666	S2886	H22	DMSO	BRD-K11853856-001-02-5	CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1	2.811874075	um	ASG003	trt_cp	BRD-K11853856	PJ-34	10 um
0.00337	-666	0.952093881	0.952093881	C-5001-01-LM3-035	295.3358	12	PJ34	-666	S2886	H23	DMSO	BRD-K11853856-001-02-5	CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1	0.281187408	um	ASG003	trt_cp	BRD-K11853856	PJ-34	1 um
0.00034	-666	0.095209389	0.095209389	C-5001-01-LM3-035	295.3358	12	PJ34	-666	S2886	H24	DMSO	BRD-K11853856-001-02-5	CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1	0.028118741	um	ASG003	trt_cp	BRD-K11853856	PJ-34	100 nm
0.03616	-666	10	10	C-5001-01-LM3-035	301.32044	12	NOCODAZOLE	-666	1228	I01	DMSO	BRD-K12539581-001-12-0	COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1cccs1	3.0132044	um	ASG003	trt_cp	BRD-K12539581	nocodazole	10 um
0.00362	-666	1	1	C-5001-01-LM3-035	301.32044	12	NOCODAZOLE	-666	1228	I02	DMSO	BRD-K12539581-001-12-0	COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1cccs1	0.30132044	um	ASG003	trt_cp	BRD-K12539581	nocodazole	1 um
0.00036	-666	0.1	0.1	C-5001-01-LM3-035	301.32044	12	NOCODAZOLE	-666	1228	I03	DMSO	BRD-K12539581-001-12-0	COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1cccs1	0.030132044	um	ASG003	trt_cp	BRD-K12539581	nocodazole	100 nm
0.05404	-666	10	10	C-5001-01-LM3-035	450.337	12	PF-2341066(CRIZOTINIB)	-666	S1068	I04	DMSO	BRD-K78431006-001-01-1	C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl	4.50337	um	ASG003	trt_cp	BRD-K78431006	crizotinib	10 um
0.0054	-666	1	1	C-5001-01-LM3-035	450.337	12	PF-2341066(CRIZOTINIB)	-666	S1068	I05	DMSO	BRD-K78431006-001-01-1	C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl	0.450337	um	ASG003	trt_cp	BRD-K78431006	crizotinib	1 um
0.00054	-666	0.1	0.1	C-5001-01-LM3-035	450.337	12	PF-2341066(CRIZOTINIB)	-666	S1068	I06	DMSO	BRD-K78431006-001-01-1	C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl	0.0450337	um	ASG003	trt_cp	BRD-K78431006	crizotinib	100 nm
0.09179	-666	10	10	C-5001-01-LM3-035	764.9391	12	DIGITOXIN	-666	1500246	I07	DMSO	BRD-A93236127-001-04-5	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	7.649391	um	ASG003	trt_cp	BRD-A93236127	digitoxin	10 um
0.00918	-666	1	1	C-5001-01-LM3-035	764.9391	12	DIGITOXIN	-666	1500246	I08	DMSO	BRD-A93236127-001-04-5	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	0.7649391	um	ASG003	trt_cp	BRD-A93236127	digitoxin	1 um
0.00092	-666	0.1	0.1	C-5001-01-LM3-035	764.9391	12	DIGITOXIN	-666	1500246	I09	DMSO	BRD-A93236127-001-04-5	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	0.07649391	um	ASG003	trt_cp	BRD-A93236127	digitoxin	100 nm
0.0233	-666	10	10	C-5001-01-LM3-035	194.1508	12	TEMOZOLOMIDE	-666	76899	I10	DMSO	BRD-K32107296-001-06-0	Cn1nnc2c(ncn2c1=O)C(N)=O	1.941508	um	ASG003	trt_cp	BRD-K32107296	temozolomide	10 um
0.00233	-666	1	1	C-5001-01-LM3-035	194.1508	12	TEMOZOLOMIDE	-666	76899	I11	DMSO	BRD-K32107296-001-06-0	Cn1nnc2c(ncn2c1=O)C(N)=O	0.1941508	um	ASG003	trt_cp	BRD-K32107296	temozolomide	1 um
0.00023	-666	0.1	0.1	C-5001-01-LM3-035	194.1508	12	TEMOZOLOMIDE	-666	76899	I12	DMSO	BRD-K32107296-001-06-0	Cn1nnc2c(ncn2c1=O)C(N)=O	0.01941508	um	ASG003	trt_cp	BRD-K32107296	temozolomide	100 nm
0.06121	-666	10	10	C-5001-01-LM3-035	510.04422	12	RALOXIFENE HYDROCHLORIDE	-666	2280	I13	DMSO	BRD-K63828191-003-07-3	Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1	5.1004422	um	ASG003	trt_cp	BRD-K63828191	raloxifene	10 um
0.00612	-666	1	1	C-5001-01-LM3-035	510.04422	12	RALOXIFENE HYDROCHLORIDE	-666	2280	I14	DMSO	BRD-K63828191-003-07-3	Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1	0.51004422	um	ASG003	trt_cp	BRD-K63828191	raloxifene	1 um
0.00061	-666	0.1	0.1	C-5001-01-LM3-035	510.04422	12	RALOXIFENE HYDROCHLORIDE	-666	2280	I15	DMSO	BRD-K63828191-003-07-3	Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1	0.051004422	um	ASG003	trt_cp	BRD-K63828191	raloxifene	100 nm
0.04397	-666	10	10	C-5001-01-LM3-035	366.4055	12	DIACETOXYSCIRPENOL	-666	NP563	I16	DMSO	BRD-K45724504-001-01-6	CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]11CO1	3.664055	um	ASG003	trt_cp	BRD-K45724504	anguidine	10 um
0.0044	-666	1	1	C-5001-01-LM3-035	366.4055	12	DIACETOXYSCIRPENOL	-666	NP563	I17	DMSO	BRD-K45724504-001-01-6	CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]11CO1	0.3664055	um	ASG003	trt_cp	BRD-K45724504	anguidine	1 um
0.00044	-666	0.1	0.1	C-5001-01-LM3-035	366.4055	12	DIACETOXYSCIRPENOL	-666	NP563	I18	DMSO	BRD-K45724504-001-01-6	CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]11CO1	0.03664055	um	ASG003	trt_cp	BRD-K45724504	anguidine	100 nm
0.03087	-666	10	10	C-5001-01-LM3-035	257.268	12	PI 3-KGAMMA INHIBITOR	-666	528106	I19	DMSO	BRD-K41895714-001-01-4	O=C1NC(=O)\C(S1)=C/c1ccc2nccnc2c1	2.57268	um	ASG003	trt_cp	BRD-K41895714	AS-605240	10 um
0.00309	-666	1	1	C-5001-01-LM3-035	257.268	12	PI 3-KGAMMA INHIBITOR	-666	528106	I20	DMSO	BRD-K41895714-001-01-4	O=C1NC(=O)\C(S1)=C/c1ccc2nccnc2c1	0.257268	um	ASG003	trt_cp	BRD-K41895714	AS-605240	1 um
0.00031	-666	0.1	0.1	C-5001-01-LM3-035	257.268	12	PI 3-KGAMMA INHIBITOR	-666	528106	I21	DMSO	BRD-K41895714-001-01-4	O=C1NC(=O)\C(S1)=C/c1ccc2nccnc2c1	0.0257268	um	ASG003	trt_cp	BRD-K41895714	AS-605240	100 nm
0.05442	-666	10	10	C-5001-01-LM3-035	453.498	12	GW501516	-666	420-032	I22	DMSO	BRD-K14880289-001-01-4	Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F	4.53498	um	ASG003	trt_cp	BRD-K14880289	GW-501516	10 um
0.00544	-666	1	1	C-5001-01-LM3-035	453.498	12	GW501516	-666	420-032	I23	DMSO	BRD-K14880289-001-01-4	Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F	0.453498	um	ASG003	trt_cp	BRD-K14880289	GW-501516	1 um
0.00054	-666	0.1	0.1	C-5001-01-LM3-035	453.498	12	GW501516	-666	420-032	I24	DMSO	BRD-K14880289-001-01-4	Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F	0.0453498	um	ASG003	trt_cp	BRD-K14880289	GW-501516	100 nm
0.06018	-666	10	10	C-5001-01-LM3-035	501.5057	12	CABOZANTINIB (XL184, BMS-907351)	-666	S1119	J01	DMSO	BRD-K51544265-001-04-2	COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC	5.015057	um	ASG003	trt_cp	BRD-K51544265	cabozantinib	10 um
0.00602	-666	1	1	C-5001-01-LM3-035	501.5057	12	CABOZANTINIB (XL184, BMS-907351)	-666	S1119	J02	DMSO	BRD-K51544265-001-04-2	COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC	0.5015057	um	ASG003	trt_cp	BRD-K51544265	cabozantinib	1 um
0.0006	-666	0.1	0.1	C-5001-01-LM3-035	501.5057	12	CABOZANTINIB (XL184, BMS-907351)	-666	S1119	J03	DMSO	BRD-K51544265-001-04-2	COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC	0.05015057	um	ASG003	trt_cp	BRD-K51544265	cabozantinib	100 nm
0.05768	-666	10	10	C-5001-01-LM3-035	480.6389	12	EMETINE	-666	S4323	J04	DMSO	BRD-K03067624-001-02-3	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc12	4.806389	um	ASG003	trt_cp	BRD-K03067624	emetine	10 um
0.00577	-666	1	1	C-5001-01-LM3-035	480.6389	12	EMETINE	-666	S4323	J05	DMSO	BRD-K03067624-001-02-3	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc12	0.4806389	um	ASG003	trt_cp	BRD-K03067624	emetine	1 um
0.00058	-666	0.1	0.1	C-5001-01-LM3-035	480.6389	12	EMETINE	-666	S4323	J06	DMSO	BRD-K03067624-001-02-3	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc12	0.04806389	um	ASG003	trt_cp	BRD-K03067624	emetine	100 nm
0.05286	-666	10	10	C-5001-01-LM3-035	440.4971	12	PCI-32765 (IBRUTINIB)	-666	S2680	J07	DMSO	BRD-A35869383-001-03-5	Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)C1CCCN(C1)C(=O)C=C	4.404971	um	ASG003	trt_cp	BRD-A35869383	ibrutinib	10 um
0.00529	-666	1	1	C-5001-01-LM3-035	440.4971	12	PCI-32765 (IBRUTINIB)	-666	S2680	J08	DMSO	BRD-A35869383-001-03-5	Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)C1CCCN(C1)C(=O)C=C	0.4404971	um	ASG003	trt_cp	BRD-A35869383	ibrutinib	1 um
0.00053	-666	0.1	0.1	C-5001-01-LM3-035	440.4971	12	PCI-32765 (IBRUTINIB)	-666	S2680	J09	DMSO	BRD-A35869383-001-03-5	Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)C1CCCN(C1)C(=O)C=C	0.04404971	um	ASG003	trt_cp	BRD-A35869383	ibrutinib	100 nm
0.06209	-666	10	10	C-5001-01-LM3-035	517.403	12	MITOXANTRONE DIHYDROCHLORIDE	-666	M6545	J10	DMSO	BRD-K21680192-300-10-2	OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12	5.17403	um	ASG003	trt_cp	BRD-K21680192	mitoxantrone	10 um
0.00621	-666	1	1	C-5001-01-LM3-035	517.403	12	MITOXANTRONE DIHYDROCHLORIDE	-666	M6545	J11	DMSO	BRD-K21680192-300-10-2	OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12	0.517403	um	ASG003	trt_cp	BRD-K21680192	mitoxantrone	1 um
0.00062	-666	0.1	0.1	C-5001-01-LM3-035	517.403	12	MITOXANTRONE DIHYDROCHLORIDE	-666	M6545	J12	DMSO	BRD-K21680192-300-10-2	OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12	0.0517403	um	ASG003	trt_cp	BRD-K21680192	mitoxantrone	100 nm
0.05484	-666	10.12105873	10.12105873	C-5001-01-LM3-035	451.5197	12	AZ628	-666	S2746	J13	DMSO	BRD-K05804044-001-09-4	Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1	4.569857401	um	ASG003	trt_cp	BRD-K05804044	AZ-628	10 um
0.00548	-666	1.012105873	1.012105873	C-5001-01-LM3-035	451.5197	12	AZ628	-666	S2746	J14	DMSO	BRD-K05804044-001-09-4	Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1	0.45698574	um	ASG003	trt_cp	BRD-K05804044	AZ-628	1 um
0.00055	-666	0.101210587	0.101210587	C-5001-01-LM3-035	451.5197	12	AZ628	-666	S2746	J15	DMSO	BRD-K05804044-001-09-4	Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1	0.045698574	um	ASG003	trt_cp	BRD-K05804044	AZ-628	100 nm
0.05023	-666	10	10	C-5001-01-LM3-035	418.56622	12	-666	-666	S6196	J16	DMSO	BRD-K22134346-001-08-2	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	4.1856622	um	ASG003	trt_cp	BRD-K22134346	simvastatin	10 um
0.00502	-666	1	1	C-5001-01-LM3-035	418.56622	12	-666	-666	S6196	J17	DMSO	BRD-K22134346-001-08-2	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	0.41856622	um	ASG003	trt_cp	BRD-K22134346	simvastatin	1 um
0.0005	-666	0.1	0.1	C-5001-01-LM3-035	418.56622	12	-666	-666	S6196	J18	DMSO	BRD-K22134346-001-08-2	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	0.041856622	um	ASG003	trt_cp	BRD-K22134346	simvastatin	100 nm
0.04822	-666	10	10	C-5001-01-LM3-035	401.84	12	FLAVOPIRIDOL	-666	S1230	J19	DMSO	BRD-K87909389-001-01-2	CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl	4.0184	um	ASG003	trt_cp	BRD-K87909389	alvocidib	10 um
0.00482	-666	1	1	C-5001-01-LM3-035	401.84	12	FLAVOPIRIDOL	-666	S1230	J20	DMSO	BRD-K87909389-001-01-2	CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl	0.40184	um	ASG003	trt_cp	BRD-K87909389	alvocidib	1 um
0.00048	-666	0.1	0.1	C-5001-01-LM3-035	401.84	12	FLAVOPIRIDOL	-666	S1230	J21	DMSO	BRD-K87909389-001-01-2	CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl	0.040184	um	ASG003	trt_cp	BRD-K87909389	alvocidib	100 nm
0.03327	-666	10	10	C-5001-01-LM3-035	277.263	12	AZATHIOPRINE	-666	S1721	J22	DMSO	BRD-K32821942-001-20-5	Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O	2.77263	um	ASG003	trt_cp	BRD-K32821942	azathioprine	10 um
0.00333	-666	1	1	C-5001-01-LM3-035	277.263	12	AZATHIOPRINE	-666	S1721	J23	DMSO	BRD-K32821942-001-20-5	Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O	0.277263	um	ASG003	trt_cp	BRD-K32821942	azathioprine	1 um
0.00033	-666	0.1	0.1	C-5001-01-LM3-035	277.263	12	AZATHIOPRINE	-666	S1721	J24	DMSO	BRD-K32821942-001-20-5	Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O	0.0277263	um	ASG003	trt_cp	BRD-K32821942	azathioprine	100 nm
0.04872	-666	9.634648532	9.634648532	C-5001-01-LM3-035	421.3593	12	RUCAPARIB (AG-014699 , PF-01367338)	-666	S1098	K01	DMSO	BRD-K88560311-011-07-1	CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23	4.059648761	um	ASG003	trt_cp	BRD-K88560311	rucaparib	10 um
0.00487	-666	0.963464853	0.963464853	C-5001-01-LM3-035	421.3593	12	RUCAPARIB (AG-014699 , PF-01367338)	-666	S1098	K02	DMSO	BRD-K88560311-011-07-1	CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23	0.405964876	um	ASG003	trt_cp	BRD-K88560311	rucaparib	1 um
0.00049	-666	0.096346486	0.096346486	C-5001-01-LM3-035	421.3593	12	RUCAPARIB (AG-014699 , PF-01367338)	-666	S1098	K03	DMSO	BRD-K88560311-011-07-1	CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23	0.040596488	um	ASG003	trt_cp	BRD-K88560311	rucaparib	100 nm
0.05923	-666	10	10	C-5001-01-LM3-035	493.6027	12	IMATINIB	-666	S2475	K04	DMSO	BRD-K92723993-001-07-5	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1	4.936027	um	ASG003	trt_cp	BRD-K92723993	imatinib	10 um
0.00592	-666	1	1	C-5001-01-LM3-035	493.6027	12	IMATINIB	-666	S2475	K05	DMSO	BRD-K92723993-001-07-5	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1	0.4936027	um	ASG003	trt_cp	BRD-K92723993	imatinib	1 um
0.00059	-666	0.1	0.1	C-5001-01-LM3-035	493.6027	12	IMATINIB	-666	S2475	K06	DMSO	BRD-K92723993-001-07-5	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1	0.04936027	um	ASG003	trt_cp	BRD-K92723993	imatinib	100 nm
0.04636	-666	10.05369082	10.05369082	C-5001-01-LM3-035	384.237	12	BORTEZOMIB	-666	S1013	K07	DMSO	BRD-K88510285-001-23-6	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	3.863	um	ASG003	trt_cp	BRD-K88510285	bortezomib	10 um
0.04636	-666	10.05369082	10.05369082	C-5001-01-LM3-035	384.237	12	BORTEZOMIB	-666	S1013	K08	DMSO	BRD-K88510285-001-23-6	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	3.863	um	ASG003	trt_cp	BRD-K88510285	bortezomib	10 um
0.04636	-666	10.05369082	10.05369082	C-5001-01-LM3-035	384.237	12	BORTEZOMIB	-666	S1013	K09	DMSO	BRD-K88510285-001-23-6	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	3.863	um	ASG003	trt_cp	BRD-K88510285	bortezomib	10 um
0.04636	-666	10.05369082	10.05369082	C-5001-01-LM3-035	384.237	12	BORTEZOMIB	-666	S1013	K10	DMSO	BRD-K88510285-001-23-6	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	3.863	um	ASG003	trt_cp	BRD-K88510285	bortezomib	10 um
0.04636	-666	10.05369082	10.05369082	C-5001-01-LM3-035	384.237	12	BORTEZOMIB	-666	S1013	K11	DMSO	BRD-K88510285-001-23-6	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	3.863	um	ASG003	trt_cp	BRD-K88510285	bortezomib	10 um
0.04636	-666	10.05369082	10.05369082	C-5001-01-LM3-035	384.237	12	BORTEZOMIB	-666	S1013	K12	DMSO	BRD-K88510285-001-23-6	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	3.863	um	ASG003	trt_cp	BRD-K88510285	bortezomib	10 um
0.03428	-666	10	10	C-5001-01-LM3-035	285.689	12	CGS 15943	-666	1699	K13	DMSO	BRD-K49049886-001-08-7	Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1	2.85689	um	ASG003	trt_cp	BRD-K49049886	CGS-15943	10 um
0.00343	-666	1	1	C-5001-01-LM3-035	285.689	12	CGS 15943	-666	1699	K14	DMSO	BRD-K49049886-001-08-7	Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1	0.285689	um	ASG003	trt_cp	BRD-K49049886	CGS-15943	1 um
0.00034	-666	0.1	0.1	C-5001-01-LM3-035	285.689	12	CGS 15943	-666	1699	K15	DMSO	BRD-K49049886-001-08-7	Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1	0.0285689	um	ASG003	trt_cp	BRD-K49049886	CGS-15943	100 nm
0.0537	-666	10	10	C-5001-01-LM3-035	447.5328	12	PALBOCICLIB	-666	S1116	K16	DMSO	BRD-K51313569-001-06-0	CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O	4.475328	um	ASG003	trt_cp	BRD-K51313569	palbociclib	10 um
0.00537	-666	1	1	C-5001-01-LM3-035	447.5328	12	PALBOCICLIB	-666	S1116	K17	DMSO	BRD-K51313569-001-06-0	CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O	0.4475328	um	ASG003	trt_cp	BRD-K51313569	palbociclib	1 um
0.00054	-666	0.1	0.1	C-5001-01-LM3-035	447.5328	12	PALBOCICLIB	-666	S1116	K18	DMSO	BRD-K51313569-001-06-0	CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O	0.04475328	um	ASG003	trt_cp	BRD-K51313569	palbociclib	100 nm
0.03844	-666	10	10	C-5001-01-LM3-035	320.3371	12	MYCOPHENOLIC ACID	-666	S2487	K19	DMSO	BRD-K63750851-001-18-1	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O	3.203371	um	ASG003	trt_cp	BRD-K63750851	mycophenolic-acid	10 um
0.00384	-666	1	1	C-5001-01-LM3-035	320.3371	12	MYCOPHENOLIC ACID	-666	S2487	K20	DMSO	BRD-K63750851-001-18-1	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O	0.3203371	um	ASG003	trt_cp	BRD-K63750851	mycophenolic-acid	1 um
0.00038	-666	0.1	0.1	C-5001-01-LM3-035	320.3371	12	MYCOPHENOLIC ACID	-666	S2487	K21	DMSO	BRD-K63750851-001-18-1	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O	0.03203371	um	ASG003	trt_cp	BRD-K63750851	mycophenolic-acid	100 nm
0.07544	-666	10	10	C-5001-01-LM3-035	628.629	12	R406	-666	S2194	K22	DMSO	BRD-K20285085-074-03-7	COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC	6.28629	um	ASG003	trt_cp	BRD-K20285085	fostamatinib	10 um
0.00754	-666	1	1	C-5001-01-LM3-035	628.629	12	R406	-666	S2194	K23	DMSO	BRD-K20285085-074-03-7	COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC	0.628629	um	ASG003	trt_cp	BRD-K20285085	fostamatinib	1 um
0.00075	-666	0.1	0.1	C-5001-01-LM3-035	628.629	12	R406	-666	S2194	K24	DMSO	BRD-K20285085-074-03-7	COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC	0.0628629	um	ASG003	trt_cp	BRD-K20285085	fostamatinib	100 nm
0.09761	-666	10	10	C-5001-01-LM3-035	813.427	12	ABT-737	-666	S1002	L01	DMSO	BRD-K56301217-001-10-8	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1	8.13427	um	ASG003	trt_cp	BRD-K56301217	ABT-737	10 um
0.00976	-666	1	1	C-5001-01-LM3-035	813.427	12	ABT-737	-666	S1002	L02	DMSO	BRD-K56301217-001-10-8	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1	0.813427	um	ASG003	trt_cp	BRD-K56301217	ABT-737	1 um
0.00098	-666	0.1	0.1	C-5001-01-LM3-035	813.427	12	ABT-737	-666	S1002	L03	DMSO	BRD-K56301217-001-10-8	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1	0.0813427	um	ASG003	trt_cp	BRD-K56301217	ABT-737	100 nm
0.04517	-666	10	10	C-5001-01-LM3-035	376.4085	12	MS-275(ENTINOSTAT)	-666	S1053	L04	DMSO	BRD-K77908580-001-05-4	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1	3.764085	um	ASG003	trt_cp	BRD-K77908580	entinostat	10 um
0.00452	-666	1	1	C-5001-01-LM3-035	376.4085	12	MS-275(ENTINOSTAT)	-666	S1053	L05	DMSO	BRD-K77908580-001-05-4	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1	0.3764085	um	ASG003	trt_cp	BRD-K77908580	entinostat	1 um
0.00045	-666	0.1	0.1	C-5001-01-LM3-035	376.4085	12	MS-275(ENTINOSTAT)	-666	S1053	L06	DMSO	BRD-K77908580-001-05-4	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1	0.03764085	um	ASG003	trt_cp	BRD-K77908580	entinostat	100 nm
0.04253	-666	10	10	C-5001-01-LM3-035	354.4493	12	ROSCOVITINE(CYC202)	-666	S1153	L07	DMSO	BRD-K07691486-001-07-2	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	3.544493	um	ASG003	trt_cp	BRD-K07691486	roscovitine	10 um
0.00425	-666	1	1	C-5001-01-LM3-035	354.4493	12	ROSCOVITINE(CYC202)	-666	S1153	L08	DMSO	BRD-K07691486-001-07-2	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	0.3544493	um	ASG003	trt_cp	BRD-K07691486	roscovitine	1 um
0.00043	-666	0.1	0.1	C-5001-01-LM3-035	354.4493	12	ROSCOVITINE(CYC202)	-666	S1153	L09	DMSO	BRD-K07691486-001-07-2	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	0.03544493	um	ASG003	trt_cp	BRD-K07691486	roscovitine	100 nm
0.05587	-666	10	10	C-5001-01-LM3-035	465.5447	12	AZD8055	-666	S1555	L10	DMSO	BRD-K69932463-001-10-6	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C	4.655447	um	ASG003	trt_cp	BRD-K69932463	AZD-8055	10 um
0.00559	-666	1	1	C-5001-01-LM3-035	465.5447	12	AZD8055	-666	S1555	L11	DMSO	BRD-K69932463-001-10-6	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C	0.4655447	um	ASG003	trt_cp	BRD-K69932463	AZD-8055	1 um
0.00056	-666	0.1	0.1	C-5001-01-LM3-035	465.5447	12	AZD8055	-666	S1555	L12	DMSO	BRD-K69932463-001-10-6	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C	0.04655447	um	ASG003	trt_cp	BRD-K69932463	AZD-8055	100 nm
0.06044	-666	10	10	C-5001-01-LM3-035	503.6358	12	XL888	-666	S7122	L13	DMSO	BRD-A03506276-001-01-5	CC[C@@H](C)Nc1cc(C(=O)NC2CC3CCC(C2)N3c2ccc(cn2)C(=O)C2CC2)c(C)cc1C(N)=O	5.036358	um	ASG003	trt_cp	BRD-A03506276	xl888	10 um
0.00604	-666	1	1	C-5001-01-LM3-035	503.6358	12	XL888	-666	S7122	L14	DMSO	BRD-A03506276-001-01-5	CC[C@@H](C)Nc1cc(C(=O)NC2CC3CCC(C2)N3c2ccc(cn2)C(=O)C2CC2)c(C)cc1C(N)=O	0.5036358	um	ASG003	trt_cp	BRD-A03506276	xl888	1 um
0.0006	-666	0.1	0.1	C-5001-01-LM3-035	503.6358	12	XL888	-666	S7122	L15	DMSO	BRD-A03506276-001-01-5	CC[C@@H](C)Nc1cc(C(=O)NC2CC3CCC(C2)N3c2ccc(cn2)C(=O)C2CC2)c(C)cc1C(N)=O	0.05036358	um	ASG003	trt_cp	BRD-A03506276	xl888	100 nm
0.06978	-666	10	10	C-5001-01-LM3-035	581.49	12	NUTLIN-3	-666	S1061	L16	DMSO	BRD-A12230535-001-10-9	COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1	5.8149	um	ASG003	trt_cp	BRD-A12230535	nutlin-3	10 um
0.00698	-666	1	1	C-5001-01-LM3-035	581.49	12	NUTLIN-3	-666	S1061	L17	DMSO	BRD-A12230535-001-10-9	COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1	0.58149	um	ASG003	trt_cp	BRD-A12230535	nutlin-3	1 um
0.0007	-666	0.1	0.1	C-5001-01-LM3-035	581.49	12	NUTLIN-3	-666	S1061	L18	DMSO	BRD-A12230535-001-10-9	COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1	0.058149	um	ASG003	trt_cp	BRD-A12230535	nutlin-3	100 nm
0.06497	-666	10	10	C-5001-01-LM3-035	541.457	12	LOMERIZINE HCL	-666	S4084	L19	DMSO	BRD-K62858456-300-01-4	COc1ccc(CN2CCN(CC2)C(c2ccc(F)cc2)c2ccc(F)cc2)c(OC)c1OC	5.41457	um	ASG003	trt_cp	BRD-K62858456	lomerizine	10 um
0.0065	-666	1	1	C-5001-01-LM3-035	541.457	12	LOMERIZINE HCL	-666	S4084	L20	DMSO	BRD-K62858456-300-01-4	COc1ccc(CN2CCN(CC2)C(c2ccc(F)cc2)c2ccc(F)cc2)c(OC)c1OC	0.541457	um	ASG003	trt_cp	BRD-K62858456	lomerizine	1 um
0.00065	-666	0.1	0.1	C-5001-01-LM3-035	541.457	12	LOMERIZINE HCL	-666	S4084	L21	DMSO	BRD-K62858456-300-01-4	COc1ccc(CN2CCN(CC2)C(c2ccc(F)cc2)c2ccc(F)cc2)c(OC)c1OC	0.0541457	um	ASG003	trt_cp	BRD-K62858456	lomerizine	100 nm
0.04732	-666	10	10	C-5001-01-LM3-035	394.356	12	JNJ-7706621	-666	S1249	L22	DMSO	BRD-K11636097-001-01-5	Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F	3.94356	um	ASG003	trt_cp	BRD-K11636097	JNJ-7706621	10 um
0.00473	-666	1	1	C-5001-01-LM3-035	394.356	12	JNJ-7706621	-666	S1249	L23	DMSO	BRD-K11636097-001-01-5	Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F	0.394356	um	ASG003	trt_cp	BRD-K11636097	JNJ-7706621	1 um
0.00047	-666	0.1	0.1	C-5001-01-LM3-035	394.356	12	JNJ-7706621	-666	S1249	L24	DMSO	BRD-K11636097-001-01-5	Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F	0.0394356	um	ASG003	trt_cp	BRD-K11636097	JNJ-7706621	100 nm
0.04884	-666	10	10	C-5001-01-LM3-035	407.035	12	THIORIDAZINE HYDROCHLORIDE	-666	T9025	M01	DMSO	BRD-A84481105-003-18-0	CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1	4.07035	um	ASG003	trt_cp	BRD-A84481105	thioridazine	10 um
0.00488	-666	1	1	C-5001-01-LM3-035	407.035	12	THIORIDAZINE HYDROCHLORIDE	-666	T9025	M02	DMSO	BRD-A84481105-003-18-0	CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1	0.407035	um	ASG003	trt_cp	BRD-A84481105	thioridazine	1 um
0.00049	-666	0.1	0.1	C-5001-01-LM3-035	407.035	12	THIORIDAZINE HYDROCHLORIDE	-666	T9025	M03	DMSO	BRD-A84481105-003-18-0	CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1	0.0407035	um	ASG003	trt_cp	BRD-A84481105	thioridazine	100 nm
0.03196	-666	10	10	C-5001-01-LM3-035	266.3343	12	DIENESTROL	-666	1500241	M04	DMSO	BRD-K95309561-001-24-7	C\C=C(c1ccc(O)cc1)\C(c1ccc(O)cc1)=C\C	2.663343	um	ASG003	trt_cp	BRD-K95309561	dienestrol	10 um
0.0032	-666	1	1	C-5001-01-LM3-035	266.3343	12	DIENESTROL	-666	1500241	M05	DMSO	BRD-K95309561-001-24-7	C\C=C(c1ccc(O)cc1)\C(c1ccc(O)cc1)=C\C	0.2663343	um	ASG003	trt_cp	BRD-K95309561	dienestrol	1 um
0.00032	-666	0.1	0.1	C-5001-01-LM3-035	266.3343	12	DIENESTROL	-666	1500241	M06	DMSO	BRD-K95309561-001-24-7	C\C=C(c1ccc(O)cc1)\C(c1ccc(O)cc1)=C\C	0.02663343	um	ASG003	trt_cp	BRD-K95309561	dienestrol	100 nm
0.04387	-666	9.842716731	9.842716731	C-5001-01-LM3-035	371.41	12	ABT-751	-666	S1165	M07	DMSO	BRD-K91623615-001-05-0	COc1ccc(cc1)S(=O)(=O)Nc1cccnc1Nc1ccc(O)cc1	3.655683421	um	ASG003	trt_cp	BRD-K91623615	ABT-751	10 um
0.00439	-666	0.984271673	0.984271673	C-5001-01-LM3-035	371.41	12	ABT-751	-666	S1165	M08	DMSO	BRD-K91623615-001-05-0	COc1ccc(cc1)S(=O)(=O)Nc1cccnc1Nc1ccc(O)cc1	0.365568342	um	ASG003	trt_cp	BRD-K91623615	ABT-751	1 um
0.00044	-666	0.098427167	0.098427167	C-5001-01-LM3-035	371.41	12	ABT-751	-666	S1165	M09	DMSO	BRD-K91623615-001-05-0	COc1ccc(cc1)S(=O)(=O)Nc1cccnc1Nc1ccc(O)cc1	0.036556834	um	ASG003	trt_cp	BRD-K91623615	ABT-751	100 nm
0.03854	-666	10	10	C-5001-01-LM3-035	321.158	12	LORAZEPAM	-666	AC3164	M10	DMSO	BRD-A11990600-001-03-4	OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O	3.21158	um	ASG003	trt_cp	BRD-A11990600	lorazepam	10 um
0.00385	-666	1	1	C-5001-01-LM3-035	321.158	12	LORAZEPAM	-666	AC3164	M11	DMSO	BRD-A11990600-001-03-4	OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O	0.321158	um	ASG003	trt_cp	BRD-A11990600	lorazepam	1 um
0.00039	-666	0.1	0.1	C-5001-01-LM3-035	321.158	12	LORAZEPAM	-666	AC3164	M12	DMSO	BRD-A11990600-001-03-4	OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O	0.0321158	um	ASG003	trt_cp	BRD-A11990600	lorazepam	100 nm
0.05586	-666	9.999957903	9.999957903	C-5001-01-LM3-035	465.5414	12	NVP-AUY922	-666	HY-10215	M13	DMSO	BRD-K41859756-001-09-2	CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O	4.655394402	um	ASG003	trt_cp	BRD-K41859756	NVP-AUY922	10 um
0.00559	-666	0.99999579	0.99999579	C-5001-01-LM3-035	465.5414	12	NVP-AUY922	-666	HY-10215	M14	DMSO	BRD-K41859756-001-09-2	CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O	0.46553944	um	ASG003	trt_cp	BRD-K41859756	NVP-AUY922	1 um
0.00056	-666	0.099999579	0.099999579	C-5001-01-LM3-035	465.5414	12	NVP-AUY922	-666	HY-10215	M15	DMSO	BRD-K41859756-001-09-2	CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O	0.046553944	um	ASG003	trt_cp	BRD-K41859756	NVP-AUY922	100 nm
0.04505	-666	10	10	C-5001-01-LM3-035	375.3941	12	GATIFLOXACIN	-666	1504272	M16	DMSO	BRD-A74980173-001-06-9	COc1c(N2CCNC(C)C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	3.753941	um	ASG003	trt_cp	BRD-A74980173	gatifloxacin	10 um
0.0045	-666	1	1	C-5001-01-LM3-035	375.3941	12	GATIFLOXACIN	-666	1504272	M17	DMSO	BRD-A74980173-001-06-9	COc1c(N2CCNC(C)C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	0.3753941	um	ASG003	trt_cp	BRD-A74980173	gatifloxacin	1 um
0.00045	-666	0.1	0.1	C-5001-01-LM3-035	375.3941	12	GATIFLOXACIN	-666	1504272	M18	DMSO	BRD-A74980173-001-06-9	COc1c(N2CCNC(C)C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	0.03753941	um	ASG003	trt_cp	BRD-A74980173	gatifloxacin	100 nm
0.05831	-666	10	10	C-5001-01-LM3-035	485.938	12	BIBW2992	-666	S1011	M19	DMSO	BRD-K66175015-001-01-7	CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1	4.85938	um	ASG003	trt_cp	BRD-K66175015	afatinib	10 um
0.00583	-666	1	1	C-5001-01-LM3-035	485.938	12	BIBW2992	-666	S1011	M20	DMSO	BRD-K66175015-001-01-7	CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1	0.485938	um	ASG003	trt_cp	BRD-K66175015	afatinib	1 um
0.00058	-666	0.1	0.1	C-5001-01-LM3-035	485.938	12	BIBW2992	-666	S1011	M21	DMSO	BRD-K66175015-001-01-7	CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1	0.0485938	um	ASG003	trt_cp	BRD-K66175015	afatinib	100 nm
0.05332	-666	10	10	C-5001-01-LM3-035	444.302	12	YM155	-666	S1130	M22	DMSO	BRD-K24681473-004-01-4	COCC[n+]1c(C)n(Cc2cnccn2)c2c1C(=O)c1ccccc1C2=O	4.44302	um	ASG003	trt_cp	BRD-K24681473	YM-155	10 um
0.00533	-666	1	1	C-5001-01-LM3-035	444.302	12	YM155	-666	S1130	M23	DMSO	BRD-K24681473-004-01-4	COCC[n+]1c(C)n(Cc2cnccn2)c2c1C(=O)c1ccccc1C2=O	0.444302	um	ASG003	trt_cp	BRD-K24681473	YM-155	1 um
0.00053	-666	0.1	0.1	C-5001-01-LM3-035	444.302	12	YM155	-666	S1130	M24	DMSO	BRD-K24681473-004-01-4	COCC[n+]1c(C)n(Cc2cnccn2)c2c1C(=O)c1ccccc1C2=O	0.0444302	um	ASG003	trt_cp	BRD-K24681473	YM-155	100 nm
0.05856	-666	10	10	C-5001-01-LM3-035	488.006	12	DASATINIB	-666	S1021	N01	DMSO	BRD-K49328571-001-03-6	Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1	4.88006	um	ASG003	trt_cp	BRD-K49328571	dasatinib	10 um
0.00586	-666	1	1	C-5001-01-LM3-035	488.006	12	DASATINIB	-666	S1021	N02	DMSO	BRD-K49328571-001-03-6	Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1	0.488006	um	ASG003	trt_cp	BRD-K49328571	dasatinib	1 um
0.00059	-666	0.1	0.1	C-5001-01-LM3-035	488.006	12	DASATINIB	-666	S1021	N03	DMSO	BRD-K49328571-001-03-6	Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1	0.0488006	um	ASG003	trt_cp	BRD-K49328571	dasatinib	100 nm
0.04012	-666	10	10	C-5001-01-LM3-035	334.3272	12	MITOMYCIN	-666	330002	N04	DMSO	BRD-A48237631-001-04-8	CO[C@@]12[C@@H]3NC3CN1C1=C([C@@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O	3.343272	um	ASG003	trt_cp	BRD-A48237631	mitomycin-c	10 um
0.00401	-666	1	1	C-5001-01-LM3-035	334.3272	12	MITOMYCIN	-666	330002	N05	DMSO	BRD-A48237631-001-04-8	CO[C@@]12[C@@H]3NC3CN1C1=C([C@@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O	0.3343272	um	ASG003	trt_cp	BRD-A48237631	mitomycin-c	1 um
0.0004	-666	0.1	0.1	C-5001-01-LM3-035	334.3272	12	MITOMYCIN	-666	330002	N06	DMSO	BRD-A48237631-001-04-8	CO[C@@]12[C@@H]3NC3CN1C1=C([C@@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O	0.03343272	um	ASG003	trt_cp	BRD-A48237631	mitomycin-c	100 nm
0.06353	-666	9.227868494	9.227868494	C-5001-01-LM3-035	573.699	12	TW-37	-666	S1121	N07	DMSO	BRD-K28360340-001-08-3	CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O	5.294018927	um	ASG003	trt_cp	BRD-K28360340	TW-37	10 um
0.00635	-666	0.92278685	0.92278685	C-5001-01-LM3-035	573.699	12	TW-37	-666	S1121	N08	DMSO	BRD-K28360340-001-08-3	CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O	0.529401893	um	ASG003	trt_cp	BRD-K28360340	TW-37	1 um
0.00064	-666	0.092278684	0.092278684	C-5001-01-LM3-035	573.699	12	TW-37	-666	S1121	N09	DMSO	BRD-K28360340-001-08-3	CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O	0.052940189	um	ASG003	trt_cp	BRD-K28360340	TW-37	100 nm
0.07365	-666	10	10	C-5001-01-LM3-035	613.7895	12	INDINAVIR	-666	AC2017	N10	DMSO	BRD-K33226500-001-01-0	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12	6.137895	um	ASG003	trt_cp	BRD-K33226500	indinavir	10 um
0.00737	-666	1	1	C-5001-01-LM3-035	613.7895	12	INDINAVIR	-666	AC2017	N11	DMSO	BRD-K33226500-001-01-0	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12	0.6137895	um	ASG003	trt_cp	BRD-K33226500	indinavir	1 um
0.00074	-666	0.1	0.1	C-5001-01-LM3-035	613.7895	12	INDINAVIR	-666	AC2017	N12	DMSO	BRD-K33226500-001-01-0	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12	0.06137895	um	ASG003	trt_cp	BRD-K33226500	indinavir	100 nm
0.03824	-666	9.946843583	9.946843583	C-5001-01-LM3-035	320.3883	12	AG14361	-666	S2178	N13	DMSO	BRD-K00615600-001-13-7	CN(C)Cc1ccc(cc1)-c1nc2cccc3C(=O)NCCn1c23	3.186852306	um	ASG003	trt_cp	BRD-K00615600	AG-14361	10 um
0.00382	-666	0.99468436	0.99468436	C-5001-01-LM3-035	320.3883	12	AG14361	-666	S2178	N14	DMSO	BRD-K00615600-001-13-7	CN(C)Cc1ccc(cc1)-c1nc2cccc3C(=O)NCCn1c23	0.318685231	um	ASG003	trt_cp	BRD-K00615600	AG-14361	1 um
0.00038	-666	0.099468436	0.099468436	C-5001-01-LM3-035	320.3883	12	AG14361	-666	S2178	N15	DMSO	BRD-K00615600-001-13-7	CN(C)Cc1ccc(cc1)-c1nc2cccc3C(=O)NCCn1c23	0.031868523	um	ASG003	trt_cp	BRD-K00615600	AG-14361	100 nm
0.07385	-666	10	10	C-5001-01-LM3-035	615.3948	12	TRAMETINIB	-666	S2673	N16	DMSO	BRD-K12343256-001-17-0	CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O	6.153948	um	ASG003	trt_cp	BRD-K12343256	trametinib	10 um
0.00738	-666	1	1	C-5001-01-LM3-035	615.3948	12	TRAMETINIB	-666	S2673	N17	DMSO	BRD-K12343256-001-17-0	CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O	0.6153948	um	ASG003	trt_cp	BRD-K12343256	trametinib	1 um
0.00074	-666	0.1	0.1	C-5001-01-LM3-035	615.3948	12	TRAMETINIB	-666	S2673	N18	DMSO	BRD-K12343256-001-17-0	CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O	0.06153948	um	ASG003	trt_cp	BRD-K12343256	trametinib	100 nm
0.05786	-666	10	10	C-5001-01-LM3-035	482.193	12	PD0325901	-666	S1036	N19	DMSO	BRD-K49865102-001-09-2	OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	4.82193	um	ASG003	trt_cp	BRD-K49865102	PD-0325901	10 um
0.00579	-666	1	1	C-5001-01-LM3-035	482.193	12	PD0325901	-666	S1036	N20	DMSO	BRD-K49865102-001-09-2	OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	0.482193	um	ASG003	trt_cp	BRD-K49865102	PD-0325901	1 um
0.00058	-666	0.1	0.1	C-5001-01-LM3-035	482.193	12	PD0325901	-666	S1036	N21	DMSO	BRD-K49865102-001-09-2	OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	0.0482193	um	ASG003	trt_cp	BRD-K49865102	PD-0325901	100 nm
0.05704	-666	10	10	C-5001-01-LM3-035	475.354	12	VANDETANIB (ZD6474)	-666	S1046	N22	DMSO	BRD-K77625799-001-07-7	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	4.75354	um	ASG003	trt_cp	BRD-K77625799	vandetanib	10 um
0.0057	-666	1	1	C-5001-01-LM3-035	475.354	12	VANDETANIB (ZD6474)	-666	S1046	N23	DMSO	BRD-K77625799-001-07-7	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	0.475354	um	ASG003	trt_cp	BRD-K77625799	vandetanib	1 um
0.00057	-666	0.1	0.1	C-5001-01-LM3-035	475.354	12	VANDETANIB (ZD6474)	-666	S1046	N24	DMSO	BRD-K77625799-001-07-7	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	0.0475354	um	ASG003	trt_cp	BRD-K77625799	vandetanib	100 nm
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	O01	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	O02	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	O03	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	O04	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	O05	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0	-666	-666	-666	C-5001-01-LM3-035	-666	0	DMSO	-666	-666	O06	-666	-666	-666	-666	-666	ASG003	ctl_vehicle	DMSO	DMSO	-666
0.06973	-666	10	10	C-5001-01-LM3-035	581.058	12	LAPATINIB	-666	S2111	O07	DMSO	BRD-K19687926-001-05-8	CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1	5.81058	um	ASG003	trt_cp	BRD-K19687926	lapatinib	10 um
0.00697	-666	1	1	C-5001-01-LM3-035	581.058	12	LAPATINIB	-666	S2111	O08	DMSO	BRD-K19687926-001-05-8	CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1	0.581058	um	ASG003	trt_cp	BRD-K19687926	lapatinib	1 um
0.0007	-666	0.1	0.1	C-5001-01-LM3-035	581.058	12	LAPATINIB	-666	S2111	O09	DMSO	BRD-K19687926-001-05-8	CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1	0.0581058	um	ASG003	trt_cp	BRD-K19687926	lapatinib	100 nm
0.06547	-666	10	10	C-5001-01-LM3-035	545.6213	12	HOMOHARRINGTONINE	-666	1416	O10	DMSO	BRD-K76674262-001-03-3	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC	5.456213	um	ASG003	trt_cp	BRD-K76674262	homoharringtonine	10 um
0.00655	-666	1	1	C-5001-01-LM3-035	545.6213	12	HOMOHARRINGTONINE	-666	1416	O11	DMSO	BRD-K76674262-001-03-3	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC	0.5456213	um	ASG003	trt_cp	BRD-K76674262	homoharringtonine	1 um
0.00065	-666	0.1	0.1	C-5001-01-LM3-035	545.6213	12	HOMOHARRINGTONINE	-666	1416	O12	DMSO	BRD-K76674262-001-03-3	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC	0.05456213	um	ASG003	trt_cp	BRD-K76674262	homoharringtonine	100 nm
0.03511	-666	10	10	C-5001-01-LM3-035	292.549	12	ANAGRELIDE	-666	sc-203513A	O13	DMSO	BRD-K62200014-003-08-9	Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl	2.92549	um	ASG003	trt_cp	BRD-K62200014	anagrelide	10 um
0.00351	-666	1	1	C-5001-01-LM3-035	292.549	12	ANAGRELIDE	-666	sc-203513A	O14	DMSO	BRD-K62200014-003-08-9	Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl	0.292549	um	ASG003	trt_cp	BRD-K62200014	anagrelide	1 um
0.00035	-666	0.1	0.1	C-5001-01-LM3-035	292.549	12	ANAGRELIDE	-666	sc-203513A	O15	DMSO	BRD-K62200014-003-08-9	Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl	0.0292549	um	ASG003	trt_cp	BRD-K62200014	anagrelide	100 nm
0.0424	-666	10	10	C-5001-01-LM3-035	353.3686	12	CHELIDONIN	-666	A12147	O16	DMSO	BRD-K32828673-001-02-3	CN1Cc2c3OCOc3ccc2[C@H]2[C@@H](O)Cc3cc4OCOc4cc3[C@@H]12	3.533686	um	ASG003	trt_cp	BRD-K32828673	chelidonine	10 um
0.00424	-666	1	1	C-5001-01-LM3-035	353.3686	12	CHELIDONIN	-666	A12147	O17	DMSO	BRD-K32828673-001-02-3	CN1Cc2c3OCOc3ccc2[C@H]2[C@@H](O)Cc3cc4OCOc4cc3[C@@H]12	0.3533686	um	ASG003	trt_cp	BRD-K32828673	chelidonine	1 um
0.00042	-666	0.1	0.1	C-5001-01-LM3-035	353.3686	12	CHELIDONIN	-666	A12147	O18	DMSO	BRD-K32828673-001-02-3	CN1Cc2c3OCOc3ccc2[C@H]2[C@@H](O)Cc3cc4OCOc4cc3[C@@H]12	0.03533686	um	ASG003	trt_cp	BRD-K32828673	chelidonine	100 nm
0.0633	-666	10	10	C-5001-01-LM3-035	527.5199	12	DAUNORUBICIN HYDROCHLORIDE	-666	30450-25MG	O19	DMSO	BRD-A37630846-001-02-2	COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(C)=O	5.275199	um	ASG003	trt_cp	BRD-A37630846	daunorubicin	10 um
0.00633	-666	1	1	C-5001-01-LM3-035	527.5199	12	DAUNORUBICIN HYDROCHLORIDE	-666	30450-25MG	O20	DMSO	BRD-A37630846-001-02-2	COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(C)=O	0.5275199	um	ASG003	trt_cp	BRD-A37630846	daunorubicin	1 um
0.00063	-666	0.1	0.1	C-5001-01-LM3-035	527.5199	12	DAUNORUBICIN HYDROCHLORIDE	-666	30450-25MG	O21	DMSO	BRD-A37630846-001-02-2	COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(C)=O	0.05275199	um	ASG003	trt_cp	BRD-A37630846	daunorubicin	100 nm
0.06353	-666	9.485194311	9.485194311	C-5001-01-LM3-035	558.135	12	CERITINIB (LDK378)	-666	S7083	O22	DMSO	BRD-K22149900-001-03-9	CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	5.294018927	um	ASG003	trt_cp	BRD-K22149900	ceritinib	10 um
0.00635	-666	0.948519432	0.948519432	C-5001-01-LM3-035	558.135	12	CERITINIB (LDK378)	-666	S7083	O23	DMSO	BRD-K22149900-001-03-9	CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	0.529401893	um	ASG003	trt_cp	BRD-K22149900	ceritinib	1 um
0.00064	-666	0.094851943	0.094851943	C-5001-01-LM3-035	558.135	12	CERITINIB (LDK378)	-666	S7083	O24	DMSO	BRD-K22149900-001-03-9	CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	0.052940189	um	ASG003	trt_cp	BRD-K22149900	ceritinib	100 nm
0.04193	-666	10	10	C-5001-01-LM3-035	349.4262	12	PANOBINOSTAT	-666	P180500	P01	DMSO	BRD-K02130563-001-07-2	Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1	3.494262	um	ASG003	trt_cp	BRD-K02130563	panobinostat	10 um
0.00419	-666	1	1	C-5001-01-LM3-035	349.4262	12	PANOBINOSTAT	-666	P180500	P02	DMSO	BRD-K02130563-001-07-2	Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1	0.3494262	um	ASG003	trt_cp	BRD-K02130563	panobinostat	1 um
0.00042	-666	0.1	0.1	C-5001-01-LM3-035	349.4262	12	PANOBINOSTAT	-666	P180500	P03	DMSO	BRD-K02130563-001-07-2	Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1	0.03494262	um	ASG003	trt_cp	BRD-K02130563	panobinostat	100 nm
0.04387	-666	10.11305253	10.11305253	C-5001-01-LM3-035	361.4817	12	PHA-793887	-666	S1487	P04	DMSO	BRD-K64800655-001-09-0	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	3.655683421	um	ASG003	trt_cp	BRD-K64800655	PHA-793887	10 um
0.00439	-666	1.011305253	1.011305253	C-5001-01-LM3-035	361.4817	12	PHA-793887	-666	S1487	P05	DMSO	BRD-K64800655-001-09-0	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	0.365568342	um	ASG003	trt_cp	BRD-K64800655	PHA-793887	1 um
0.00044	-666	0.101130525	0.101130525	C-5001-01-LM3-035	361.4817	12	PHA-793887	-666	S1487	P06	DMSO	BRD-K64800655-001-09-0	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	0.036556834	um	ASG003	trt_cp	BRD-K64800655	PHA-793887	100 nm
0.05526	-666	10	10	C-5001-01-LM3-035	460.5315	12	GDC-0032	-666	HY-13898	P07	DMSO	BRD-K44844162-001-01-6	CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O	4.605315	um	ASG003	trt_cp	BRD-K44844162	taselisib	10 um
0.00553	-666	1	1	C-5001-01-LM3-035	460.5315	12	GDC-0032	-666	HY-13898	P08	DMSO	BRD-K44844162-001-01-6	CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O	0.4605315	um	ASG003	trt_cp	BRD-K44844162	taselisib	1 um
0.00055	-666	0.1	0.1	C-5001-01-LM3-035	460.5315	12	GDC-0032	-666	HY-13898	P09	DMSO	BRD-K44844162-001-01-6	CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O	0.04605315	um	ASG003	trt_cp	BRD-K44844162	taselisib	100 nm
0.04332	-666	10	10	C-5001-01-LM3-035	361.029	12	MLN2238	-666	S2180	P10	DMSO	BRD-K78659596-001-03-9	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O	3.61029	um	ASG003	trt_cp	BRD-K78659596	MLN-2238	10 um
0.00433	-666	1	1	C-5001-01-LM3-035	361.029	12	MLN2238	-666	S2180	P11	DMSO	BRD-K78659596-001-03-9	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O	0.361029	um	ASG003	trt_cp	BRD-K78659596	MLN-2238	1 um
0.00043	-666	0.1	0.1	C-5001-01-LM3-035	361.029	12	MLN2238	-666	S2180	P12	DMSO	BRD-K78659596-001-03-9	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O	0.0361029	um	ASG003	trt_cp	BRD-K78659596	MLN-2238	100 nm
0.06391	-666	10	10	C-5001-01-LM3-035	532.5595	12	PONATINIB (AP24534)	-666	S1490	P13	DMSO	BRD-K44227013-001-06-4	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1	5.325595	um	ASG003	trt_cp	BRD-K44227013	ponatinib	10 um
0.00639	-666	1	1	C-5001-01-LM3-035	532.5595	12	PONATINIB (AP24534)	-666	S1490	P14	DMSO	BRD-K44227013-001-06-4	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1	0.5325595	um	ASG003	trt_cp	BRD-K44227013	ponatinib	1 um
0.00064	-666	0.1	0.1	C-5001-01-LM3-035	532.5595	12	PONATINIB (AP24534)	-666	S1490	P15	DMSO	BRD-K44227013-001-06-4	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1	0.05325595	um	ASG003	trt_cp	BRD-K44227013	ponatinib	100 nm
0.05994	-666	10	10	C-5001-01-LM3-035	499.5197	12	CGS 21680 HYDROCHLORIDE	-666	1063	P16	DMSO	BRD-A81866333-001-01-9	CCNC(=O)C1OC(C(O)C1O)n1cnc2c(N)nc(NCCc3ccc(CCC(O)=O)cc3)nc12	4.995197	um	ASG003	trt_cp	BRD-A81866333	CGS-21680	10 um
0.00599	-666	1	1	C-5001-01-LM3-035	499.5197	12	CGS 21680 HYDROCHLORIDE	-666	1063	P17	DMSO	BRD-A81866333-001-01-9	CCNC(=O)C1OC(C(O)C1O)n1cnc2c(N)nc(NCCc3ccc(CCC(O)=O)cc3)nc12	0.4995197	um	ASG003	trt_cp	BRD-A81866333	CGS-21680	1 um
0.0006	-666	0.1	0.1	C-5001-01-LM3-035	499.5197	12	CGS 21680 HYDROCHLORIDE	-666	1063	P18	DMSO	BRD-A81866333-001-01-9	CCNC(=O)C1OC(C(O)C1O)n1cnc2c(N)nc(NCCc3ccc(CCC(O)=O)cc3)nc12	0.04995197	um	ASG003	trt_cp	BRD-A81866333	CGS-21680	100 nm
0.0489	-666	10	10	C-5001-01-LM3-035	407.4955696	12	TRIFLUOPERAZINE	-666	CA-310	P19	DMSO	BRD-K89732114-001-03-4	CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	4.074955696	um	ASG003	trt_cp	BRD-K89732114	trifluoperazine	10 um
0.00489	-666	1.000000001	1.000000001	C-5001-01-LM3-035	407.4955696	12	TRIFLUOPERAZINE	-666	CA-310	P20	DMSO	BRD-K89732114-001-03-4	CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	0.40749557	um	ASG003	trt_cp	BRD-K89732114	trifluoperazine	1 um
0.00049	-666	0.1	0.1	C-5001-01-LM3-035	407.4955696	12	TRIFLUOPERAZINE	-666	CA-310	P21	DMSO	BRD-K89732114-001-03-4	CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	0.040749557	um	ASG003	trt_cp	BRD-K89732114	trifluoperazine	100 nm
0.05984	-666	10	10	C-5001-01-LM3-035	498.642	12	MASITINIB (AB1010)	-666	S1064	P22	DMSO	BRD-K71035033-001-01-4	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1	4.98642	um	ASG003	trt_cp	BRD-K71035033	masitinib	10 um
0.00598	-666	1	1	C-5001-01-LM3-035	498.642	12	MASITINIB (AB1010)	-666	S1064	P23	DMSO	BRD-K71035033-001-01-4	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1	0.498642	um	ASG003	trt_cp	BRD-K71035033	masitinib	1 um
0.0006	-666	0.1	0.1	C-5001-01-LM3-035	498.642	12	MASITINIB (AB1010)	-666	S1064	P24	DMSO	BRD-K71035033-001-01-4	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1	0.0498642	um	ASG003	trt_cp	BRD-K71035033	masitinib	100 nm